Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8101526175232858,-2.3153077937756747,0.0,0.0,0.0,7/22,3.93%,NR2F2;ALDH1A2;PTGDS;RBP1;CYP26B1;ABCA4;RBP4
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.8292882946780783,1.8890810959535724,0.0015723270440251573,0.16002511977047754,0.235,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.8292882946780783,1.8890810959535724,0.0015723270440251573,0.16002511977047754,0.235,7/16,7.87%,PTPRM;PTPRB;PTPRG;PTPRR;PTPRE;PTPRU;PTPRO
prerank,platelet-derived growth factor binding (GO:0048407),-0.7461123637002439,-1.8372513121054355,0.0026246719160104987,0.23193069652505338,0.317,7/11,2.72%,COL1A2;COL3A1;COL1A1;PDGFRB;COL5A1;PDGFRA;COL6A1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.7393092849841778,-1.8196486909794722,0.0,0.19266477724880282,0.382,5/13,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,FMN binding (GO:0010181),0.8479196032624239,1.8034736325232255,0.0034129692832764505,0.4544648151687568,0.666,2/11,0.41%,NOS1;NOS3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.8773258115146556,1.7970153885490896,0.0,0.3709450788563364,0.705,2/10,0.09%,PRDM16;MECOM
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.5697012762038763,1.7865987533332124,0.0,0.33962517773917866,0.745,29/147,7.13%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;KALRN;DOCK9;ARHGEF28;ELMO1;DENND3;ARHGEF15;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;HERC2;CYTH1;NUCB2;BCR;RAPGEF4;RAPGEF6;FGD6;SMCR8;MADD;RAB3GAP2
prerank,amino acid binding (GO:0016597),0.6918056676700843,1.7807831625113086,0.004166666666666667,0.30520591140730224,0.77,7/31,10.92%,NOS1;NOS3;CASTOR1;ASS1;GRIN2B;CAD;GRIN3A
prerank,BMP receptor binding (GO:0070700),-0.7393135219865287,-1.7727345102133534,0.0023752969121140144,0.24606642746450363,0.543,5/12,6.78%,BMP6;BMP5;BMP7;BMP4;SRC
prerank,carboxylic acid binding (GO:0031406),0.6538813770753712,1.7619078064972944,0.00410958904109589,0.33235448640840987,0.845,8/38,11.31%,NOS1;NOS3;CASTOR1;GLUD1;GRIN2B;CAD;GRIN3A;HIF1AN
prerank,P-type ion transporter activity (GO:0015662),0.821236445398241,1.7443916427234136,0.013490725126475547,0.36140229648470235,0.905,5/12,4.38%,ATP2A3;ATP2B4;ATP2B2;ATP2C1;ATP7A
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.6085317296250143,-1.7345620014873204,0.0,0.29213843941530426,0.681,5/21,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,mitogen-activated protein kinase binding (GO:0051019),0.6773718652077302,1.7255526981128833,0.005822416302765648,0.39824124267719246,0.943,6/29,8.58%,PTPRJ;ACE;DUSP1;GCH1;DUSP16;NBR1
prerank,retinoic acid binding (GO:0001972),-0.7100919282026313,-1.7147655216700335,0.010178117048346057,0.30173677523838777,0.765,2/12,2.57%,NR2F2;CYP26B1
prerank,cadherin binding (GO:0045296),0.5192002275880828,1.7049221557209089,0.0,0.4455255933915681,0.972,95/315,16.50%,PTPRM;PTPRJ;EPS8L2;PTPRB;CDH13;EHD4;LIMA1;CD2AP;MRTFB;DOCK9;BMPR2;F11R;FASN;COBLL1;FLNB;ESYT2;MACF1;DAB2IP;STXBP6;TMPO;LRRFIP1;CBL;CEMIP2;IQGAP1;PPFIBP1;SWAP70;PACSIN2;CDC42EP1;PROM1;ACVR1;SLK;STK24;EHD1;PDLIM5;SHTN1;TAGLN2;STK38;CSNK1D;FNBP1L;SH3GL1;MYH9;BSG;PLEC;FXYD5;RANGAP1;STAT1;CTNNA1;TJP2;GPRC5A;PTPRO;NUMB;CCT8;PCMT1;CDH15;CDH3;APC;TJP1;CDH12;RTN4;TRIM25;EPN2;UNC45A;RPL34;HNRNPK;PTPN1;RANBP1;CDH2;EEF2;PCBP1;KLC2;WASF2;MARK2;GCN1;CTNNA2;TMOD3;TBC1D10A;SPTAN1;CAPG;RAN;RPL23A;CTNNB1;VAPA;EIF2A;EVPL;CHMP2B;DDX6;RACK1;CDH22;PKN2;PAK2;UBFD1;AHSA1;ANK3;ATXN2L;NCK1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.567934027451462,-1.702611800727939,0.0,0.29363428395916147,0.804,8/27,6.83%,SLC22A8;SLC26A7;SLC39A14;SLC26A2;ANO1;SLC39A8;SLC22A6;SLC5A5
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.7946726707992757,1.6986136116796664,0.026622296173044926,0.4325171571889304,0.974,2/11,1.44%,KCNQ1;KCNE3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.6453376220056833,1.6979130147284789,0.014450867052023121,0.3991656147587753,0.974,3/35,3.24%,BMX;FYN;FES
prerank,solute:anion antiporter activity (GO:0140323),-0.6591627160921435,-1.6924898590073365,0.01078167115902965,0.2837617099697041,0.84,6/14,18.91%,SLC7A11;SLC26A7;SLC26A2;SLC4A2;SLC4A3;SLC26A6
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.7255674717573065,-1.6732678037876725,0.016908212560386472,0.2944653087057488,0.882,3/10,6.05%,SLC6A13;SLC6A12;SLC6A1
prerank,transferrin receptor binding (GO:1990459),-0.695400618708633,-1.659550289686336,0.02481389578163772,0.2978974409091544,0.911,5/10,16.06%,RGMA;SNX1;CD81;CHUK;SNX2
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.7720845869029465,1.6588919175513566,0.018151815181518153,0.5343205245876637,0.992,3/12,3.84%,VEGFC;DAB2IP;VEGFD
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.7316569027841615,1.650105333438475,0.04084967320261438,0.5362833961377602,0.993,2/14,1.44%,KCNQ1;KCNE3
prerank,growth factor activity (GO:0008083),0.5685650271725126,1.6486123733594633,0.011029411764705883,0.5073823980979545,0.994,4/74,0.88%,VEGFC;JAG1;JAG2;PDGFB
prerank,peptidoglycan binding (GO:0042834),0.785711626814706,1.6444849311435275,0.025728987993138937,0.4938389877320586,0.995,2/10,1.73%,NOD1;NOD2
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.5632748779193123,-1.6368678257389524,0.009259259259259259,0.32964334170583204,0.945,5/23,2.89%,PDE1A;PDE5A;PDE7B;PDE3A;PDE8B
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6928972520166132,1.6341716754418367,0.015772870662460567,0.5107331669307092,0.996,2/19,0.70%,AFAP1L2;EFNA5
prerank,chemoattractant activity (GO:0042056),0.6692380836749158,1.6302699742320308,0.013138686131386862,0.498671550599745,0.996,3/26,3.84%,VEGFC;PDGFB;VEGFD
prerank,receptor antagonist activity (GO:0048019),0.7143991930157715,1.6264626100081099,0.030254777070063694,0.4875705001215419,0.996,2/17,5.02%,DKK2;WFIKKN1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.7451837874653785,1.6237430838522782,0.028523489932885907,0.47381137908800114,0.996,6/12,16.66%,ATP2A3;NOD1;CASP1;CASP8AP2;RACK1;PYCARD
prerank,calcium-activated potassium channel activity (GO:0015269),0.7709829133770563,1.6229278552697026,0.033816425120772944,0.4540453522073663,0.996,2/11,2.72%,KCNN4;KCNN3
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.718735368159311,1.620300266447105,0.039735099337748346,0.44355030417338365,0.996,7/14,16.66%,ATP2A3;NOD1;MAL;CASP1;CASP8AP2;RACK1;PYCARD
prerank,pyridoxal phosphate binding (GO:0030170),-0.5611359734307655,-1.6178525130274484,0.021798365122615803,0.3584542141929719,0.97,13/20,34.14%,ABAT;PDXK;PYGB;PYGM;ACCS;OAT;AGXT;PLPBP;CTH;PYGL;SHMT2;GLDC;SHMT1
prerank,WW domain binding (GO:0050699),0.6479665266316127,1.6165391404081588,0.03143712574850299,0.437457314516822,0.996,7/26,9.95%,RAPGEF2;CDC25C;ENAH;TCEAL9;NDFIP2;PMEPA1;TCEAL1
prerank,anion:anion antiporter activity (GO:0015301),-0.6036551369703105,-1.6111230002636419,0.02564102564102564,0.35053390910818977,0.973,7/17,18.91%,SLC26A7;SLC26A2;SLC25A4;SLC19A1;SLC4A2;SLC4A3;SLC26A6
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6708847229499104,-1.607398702391465,0.02962962962962963,0.3359666845503192,0.979,4/11,6.05%,SLC1A3;SLC6A13;SLC6A12;SLC6A1
prerank,monocarboxylic acid binding (GO:0033293),-0.603076774608816,-1.6055855564461896,0.01662049861495845,0.31796668853923804,0.979,3/18,6.72%,NR2F2;CYP26B1;NAPEPLD
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.6957543458097153,-1.6001655675859836,0.014527845036319613,0.31124785346307954,0.983,7/10,23.28%,HAT1;USP22;ATF2;MSL3;NAA60;NAA40;NAA50
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.655911644276302,1.5968542228400684,0.03692762186115214,0.49402250277766696,0.999,4/23,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6172644923540543,-1.59645935863856,0.017543859649122806,0.3021781960302515,0.983,4/15,6.19%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,nucleoside-diphosphatase activity (GO:0017110),0.7471810829671351,1.5939330123306683,0.032520325203252036,0.4865546638550446,0.999,1/12,0.10%,ENTPD1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.5514026621841164,1.5930950297217785,0.006329113924050633,0.4711160606745534,0.999,16/71,10.63%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP1;PTPRE;CDC25C;DUSP3;PTPN12;PTPRU;PTPRO;DUSP11;CDC14A;PTPN1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.643288331991148,1.590166441045335,0.033576642335766425,0.4641072847256596,0.999,6/25,5.48%,FCHSD2;HIP1;HIP1R;TTPA;ARAP3;PLEKHA1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.7442575509347076,1.5746236186511249,0.0420032310177706,0.504474121565647,1.0,8/11,20.65%,SGMS1;SGMS2;GNPTAB;PTDSS1;PIGF;DPAGT1;AASDHPPT;PIGO
prerank,anion transmembrane transporter activity (GO:0008509),-0.6357646468986653,-1.5613549750422817,0.052083333333333336,0.37410241017121104,0.996,5/12,8.42%,SLCO2B1;SLC39A8;SLC22A6;SLC19A1;SLC4A2
prerank,growth factor receptor binding (GO:0070851),0.5226805714661537,1.557049779762335,0.013986013986013986,0.5560294945098846,1.0,12/95,8.22%,VEGFC;PTPRJ;PDGFD;HIP1;PDGFB;FYN;VEGFD;ADAM17;IL1RAP;FRS3;PLSCR1;JAK2
prerank,protein tyrosine kinase binding (GO:1990782),0.5389774556011528,1.5492415962724324,0.01905972045743329,0.5677710824394742,1.0,24/71,17.43%,CEACAM1;BMPR2;PITPNM3;PTPN14;CBL;NEDD9;CRK;ACVR1;ANGPT1;TRIM6;HYAL2;CD247;DUSP3;TJP2;PTPN1;GRM5;TOB1;DUSP22;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,alanine transmembrane transporter activity (GO:0022858),0.7144066902750686,1.547283465190624,0.05351170568561873,0.5564649770059519,1.0,1/12,0.19%,SLC6A6
prerank,leak channel activity (GO:0022840),-0.5565669348059357,-1.5455572504287205,0.032520325203252036,0.3998786109031216,0.997,3/18,2.94%,KCNK2;NALCN;KCNK5
prerank,calcium-dependent phospholipid binding (GO:0005544),0.5653146730445752,1.5454775177865248,0.028493894165535955,0.5452232005023954,1.0,9/49,6.63%,SYT15;DOC2B;MCTP1;DYSF;ESYT2;CPNE8;ANXA3;SYT7;CPNE2
prerank,sodium channel regulator activity (GO:0017080),0.5786363235203301,1.5422204094053826,0.03913630229419703,0.5414546541617715,1.0,8/37,13.00%,NOS1;ATP2B4;CAMK2D;FXYD5;SCN1B;SGK1;NEDD4L;YWHAH
prerank,voltage-gated calcium channel activity (GO:0005245),-0.4672548605257011,-1.5411591642136873,0.024193548387096774,0.3917691652589107,0.997,9/37,12.40%,CACNA2D3;CACNA1C;ITGAV;CACNG4;CACNA2D1;CACNA1G;NCS1;CACNB1;CACNB2
prerank,filamin binding (GO:0031005),0.7211986964532549,1.5378913122219389,0.048576214405360134,0.5424560814813597,1.0,3/11,2.02%,NEBL;CEACAM1;FBLIM1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.48241125038166294,-1.537518681086267,0.022222222222222223,0.38188911204673415,0.997,12/29,22.39%,SLC13A3;SLC26A7;SLC1A5;SLC26A2;SLC25A13;SLC19A1;SLC1A4;SLC25A12;SLC26A6;SLC25A18;SLC25A14;SLC13A5
prerank,Notch binding (GO:0005112),0.6402346968245307,1.536956379896905,0.045180722891566265,0.5301172906053199,1.0,6/22,6.32%,JAG1;JAG2;NOTCH4;DLL4;CUL3;ADAM17
prerank,SH3 domain binding (GO:0017124),0.5351744864180807,1.534910147980292,0.026041666666666668,0.5227867869633899,1.0,16/62,7.88%,AFAP1L2;CD2AP;ELMO1;AFAP1L1;DAB2IP;CBL;CRK;EVL;ADAM15;LANCL1;AKAP5;SHANK3;ADAM12;PTPN12;ENAH;PLSCR1
prerank,transforming growth factor beta receptor binding (GO:0005160),0.6445593228100313,1.530823981569339,0.057692307692307696,0.5241851018054027,1.0,6/18,5.38%,ENG;SMAD6;SMAD7;TGFB2;FKBP1A;SMAD2
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.610457123241161,-1.5302872661077658,0.04071246819338423,0.38385410783389196,0.997,3/14,3.00%,SLC7A11;SLC1A3;SLC25A13
prerank,sialyltransferase activity (GO:0008373),0.6483384591447781,1.5297017254845178,0.05731523378582202,0.5147436051203917,1.0,5/20,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;ST6GALNAC2;ST6GAL2
prerank,phospholipase C activity (GO:0004629),0.6197967878942507,1.5252285240162862,0.052941176470588235,0.5176818271191737,1.0,4/25,1.66%,PLCG2;PLCB1;CCR1;PLCB4
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.609001603303893,-1.5210607542931849,0.051490514905149054,0.39083816462215787,0.999,4/13,6.19%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1
prerank,BMP binding (GO:0036122),0.7078069503353579,1.5149472844089051,0.0681063122923588,0.5404640436529523,1.0,3/11,2.97%,ENG;BMPR2;UCMA
prerank,metalloendopeptidase activity (GO:0004222),-0.4004357236179094,-1.5107150117305816,0.011428571428571429,0.40151583899926,0.999,22/76,13.34%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;MMP14;ADAMTS17;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;MMP2;ADAM33;ADAMTSL4;MMP16;ZMPSTE24;MMP19;ADAMTS14
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.6965933729164285,1.509131470155761,0.06802721088435375,0.5496021977289035,1.0,3/11,11.28%,ITPR3;MCOLN1;TRPM2
prerank,actin monomer binding (GO:0003785),0.6246681812027881,1.504069384873389,0.058734939759036146,0.554320303477552,1.0,2/22,0.46%,NOS3;LIMA1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.557869755623245,1.5013222505384949,0.037889039242219216,0.5515580260690153,1.0,2/44,0.09%,PRDM16;MECOM
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.7029023347051706,1.4966071310612319,0.07425742574257425,0.5554166271266407,1.0,5/11,9.55%,MAP4K2;DAB2IP;STK38;TCF3;MAP3K11
prerank,GTPase activator activity (GO:0005096),0.4557037348241712,1.4963523235019287,0.002068252326783868,0.5438135330779816,1.0,59/313,9.67%,RASGRF2;EPS8L2;PREX2;SPATA13;FGD5;CYTH3;CCDC88C;RAPGEF2;ARHGAP31;KALRN;DOCK9;RGS3;PLCB1;ARHGEF28;RABGAP1;SIPA1L2;ELMO1;DENND3;ARHGEF15;CHN2;GNAQ;RAPGEF1;ARHGEF2;RASGRP2;RAPGEF5;ABR;ASAP2;HERC2;IQGAP1;SIPA1L3;CYTH1;RALGAPA1;ARAP3;NUCB2;BCR;TBC1D30;SGSM1;RAPGEF4;ARHGAP8;RAPGEF6;FGD6;TBC1D8;RAP1GDS1;SMCR8;MADD;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;DENND2C;DENND6B;TBC1D1;JUN;EIF2B2;RAP1GAP2
prerank,microtubule plus-end binding (GO:0051010),0.63427330311744,1.4936755702672686,0.050746268656716415,0.5423321736244785,1.0,9/20,11.08%,CLIP2;DST;TTBK2;CLIP1;CLASP1;MAPRE3;APC;CLASP2;NUMA1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5695700901246781,-1.4914073023197751,0.053475935828877004,0.43667890599913445,1.0,7/15,22.63%,SLC26A7;SLC26A2;SLC39A8;SLC4A3;SLC26A6;SLC4A8;CFTR
prerank,phosphotyrosine residue binding (GO:0001784),0.5592981192895249,1.4843048853012062,0.05106382978723404,0.5624046339568335,1.0,7/37,9.11%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.7002970848111246,1.4827364469354005,0.06199021207177814,0.5562544937995193,1.0,8/12,22.75%,PIK3R6;PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,NADP binding (GO:0050661),0.580899711448877,1.4801763122685103,0.042335766423357665,0.5542703674107198,1.0,2/32,0.41%,NOS1;NOS3
prerank,aspartic-type peptidase activity (GO:0070001),-0.6349221443142433,-1.4781457131589233,0.07142857142857142,0.45443757242380667,1.0,2/10,5.13%,BACE2;BACE1
prerank,fibroblast growth factor binding (GO:0017134),-0.5029160051358761,-1.477504794426117,0.053824362606232294,0.4394292655004398,1.0,9/21,19.59%,FGFR2;THBS1;ITGAV;KL;CEP57;GPC1;FGFRL1;FGFR4;GLG1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.6197085515717503,1.4765694342201003,0.065625,0.5554584463127915,1.0,5/22,6.93%,DUSP12;DUSP1;PPM1F;DUSP16;DUSP3
prerank,calcium activated cation channel activity (GO:0005227),0.6431569567803015,1.4718619985331325,0.06466165413533835,0.5607260237997017,1.0,2/17,3.92%,KCNN4;ANO6
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.6839702052919152,1.4716272642421202,0.07592891760904685,0.5505263147690775,1.0,4/13,3.84%,PTPRJ;PDGFD;PDGFB;VEGFD
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5390717974752562,1.4643759185658254,0.049930651872399444,0.5648108347100635,1.0,8/42,9.67%,PLCG2;SHE;CRK;SHB;BCAR3;YES1;STAP1;FBXW7
prerank,CARD domain binding (GO:0050700),0.66523933708637,1.4604189632965114,0.08955223880597014,0.5678363322334683,1.0,6/14,14.50%,NOD1;NOD2;CARD10;IRGM;CASP1;CARD19
prerank,MAP kinase phosphatase activity (GO:0033549),0.6745257814501907,1.4552835992865412,0.07705479452054795,0.5747735716949296,1.0,3/12,6.93%,DUSP1;DUSP16;DUSP3
prerank,cAMP response element binding (GO:0035497),-0.6268712016610775,-1.4522529568751097,0.08391608391608392,0.49512454401672157,1.0,6/10,13.28%,CREB5;ATF7;CREB3L1;ATF2;CREB1;HMGA2
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.6236350243600601,-1.4506141064472569,0.0861244019138756,0.48372001889096916,1.0,4/10,14.77%,PRKAG2;PRKAR2A;PRKAR2B;PRKAR1A
prerank,protein kinase binding (GO:0019901),0.4351652934641435,1.4483111344401545,0.0010121457489878543,0.5892930278834853,1.0,114/480,16.07%,PTPRJ;PLCG2;KCNQ1;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;CAVIN2;MAP4K2;TRIM14;BMPR2;ACE;CCND2;RND1;ACVRL1;NOD2;CCND3;DUSP1;DAB2IP;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;NEDD9;HDAC9;HDAC7;CRK;FBXO7;GCH1;PDE3B;TIRAP;ACVR1;MSN;PDLIM5;NBEA;PKN1;STK38;TRIM6;SPAG9;SIKE1;CDC25C;WARS1;SMCR8;DUSP16;ADIPOR1;CD247;CEP68;DUSP3;IRGM;HNRNPA0;PRKCSH;ELAVL1;HSPB1;MAPRE3;TJP2;BCL2L1;TOM1L1;JAK2;APC;NBR1;STAP1;PTK2;DSP;TCF3;ADAM10;TAOK2;MAP3K11;MAD2L2;ADCY4;CCDC88A;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;GRM5;PRKD2;VRK1;CALM3;IRF5;CTBP2;CAVIN3;PRC1;DUSP22;PPM1D;INKA1;PIN1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;NELL1;LRBA;KIZ;FRMD5;PDCD10;RACK1;NELL2;CDKN2D;PAK2;VDAC1;RICTOR;NEK9
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5988156936697143,1.4407202464107363,0.09657320872274143,0.6055524302618875,1.0,9/19,19.60%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,serotonin receptor activity (GO:0099589),0.5972238885524763,1.434696314900815,0.08638360175695461,0.5957469316144354,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5972238885524763,1.434696314900815,0.08638360175695461,0.5957469316144354,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5972238885524763,1.434696314900815,0.08638360175695461,0.5957469316144354,1.0,9/22,19.34%,HRH2;CHRM3;HTR5A;HTR1B;HTR2A;HTR1F;HRH3;HTR4;HTR6
prerank,ephrin receptor binding (GO:0046875),0.6061127060855515,1.4283557482649587,0.09618320610687023,0.6080585515558016,1.0,7/21,10.63%,EFNA5;FYN;CBL;CRK;EFNA1;ANKS1B;PTPN1
prerank,protein tyrosine kinase activity (GO:0004713),0.46380109900497,1.4277723042543118,0.03958090803259604,0.6007138090782266,1.0,15/108,9.22%,BMX;TEK;FLT1;TIE1;FYN;FLT4;MERTK;INSR;FES;FGFR3;ALK;LMTK2;JAK2;YES1;PTK2
prerank,death receptor activity (GO:0005035),0.6863518274144982,1.4216651414474162,0.10194174757281553,0.6112818200678588,1.0,3/11,5.71%,FAS;TNFRSF25;TNFRSF1B
prerank,actin binding (GO:0003779),0.4500556448514301,1.4213835137914943,0.024891774891774892,0.6026939956187424,1.0,19/170,4.46%,EPS8L2;MYRIP;NOS3;SYNPO;LIMA1;TRPV4;UTRN;CEACAM1;SYNE1;ABLIM1;NOD2;FLNB;MACF1;PARVB;KLHL2;ACTN4;FLII;VASH2;PDLIM5
prerank,wide pore channel activity (GO:0022829),0.5853034700370876,1.4209037393389332,0.0935672514619883,0.5951684670946032,1.0,4/23,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,protein phosphatase 2A binding (GO:0051721),0.5892403743084919,1.4208751063416634,0.09789156626506024,0.5862545695381604,1.0,13/23,22.01%,FOXO1;DAB2IP;CTTNBP2NL;MFHAS1;STRN3;GRIN3A;ARPP19;BOD1;STRN4;STRN;PPME1;SMG7;IGBP1
prerank,neurexin family protein binding (GO:0042043),-0.6045629026672683,-1.4172722679400052,0.1,0.5678724503329751,1.0,4/10,11.36%,NLGN2;CPE;SYTL5;SYTL4
prerank,cell-cell adhesion mediator activity (GO:0098632),0.5216598732134614,1.415304918898101,0.07869742198100407,0.5955601905995344,1.0,18/42,21.96%,IZUMO1;STXBP6;ESAM;CDC42EP1;PDLIM5;ROBO4;CD47;BSG;CD200;LRRC4C;TMOD3;MYPN;NPTN;DSCAM;CNTN4;PDLIM1;CNTN6;PAK4
prerank,cAMP binding (GO:0030552),0.6579115697524716,1.4148547301781078,0.10921501706484642,0.5881837128458863,1.0,4/11,15.62%,RAPGEF2;RAPGEF4;POPDC3;PDE4D
prerank,ATPase binding (GO:0051117),-0.37342516459054254,-1.412639991309729,0.011049723756906077,0.5642132607230018,1.0,19/71,15.64%,ANK2;EGFR;TMTC4;SNTA1;SLC2A13;ABCA1;ATP6V0A4;ATP1B3;TOR1AIP1;PTPN3;ATP5IF1;SRC;TCIRG1;METTL21A;ATP1B1;PIH1D1;ATP1B2;WFS1;ZNHIT6
prerank,gap junction channel activity (GO:0005243),0.588651551884297,1.4121799542011815,0.09792284866468842,0.5877446117705746,1.0,4/22,9.88%,GJA5;GJB1;GJA4;GJD2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.6885956629404041,1.4108688040508017,0.09475465313028765,0.5839623527491477,1.0,7/10,22.75%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,protein kinase C binding (GO:0005080),0.5287104236530196,1.4108120938632187,0.07988980716253444,0.5760132342343459,1.0,17/43,15.51%,TRPV4;CAVIN2;HDAC9;HDAC7;TIRAP;PDLIM5;PKN1;PRKCSH;HSPB1;DSP;ADCY4;CCDC88A;PRKD2;CAVIN3;NELL1;RACK1;NELL2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5799632089322998,1.4107877306766283,0.10303030303030303,0.5680946126680281,1.0,2/25,0.41%,NOS1;NOS3
prerank,LRR domain binding (GO:0030275),-0.5376949817690437,-1.409339015397937,0.09497206703910614,0.556856178536027,1.0,2/14,0.42%,ROBO1;PAWR
prerank,glutamate receptor binding (GO:0035254),0.6103052544863072,1.408095403187398,0.11975116640746501,0.5689603269724758,1.0,5/17,6.95%,HIP1;HOMER2;AKAP5;SHANK3;SHISA6
prerank,poly-pyrimidine tract binding (GO:0008187),-0.4731530281526306,-1.4065635987844634,0.08284023668639054,0.5491834592592686,1.0,10/23,22.50%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1;HNRNPU;U2AF2;PABPC1;PABPC4L;KHDRBS1
prerank,cytokine receptor binding (GO:0005126),0.480818879779291,1.4017782966622143,0.05703883495145631,0.5810582330569981,1.0,10/83,8.22%,VEGFC;KITLG;LIFR;TGFB2;FKBP1A;VEGFD;SMAD2;ADAM17;IL1RAP;JAK2
prerank,protein phosphatase binding (GO:0019903),0.4582278799380944,1.4017459300106874,0.03352601156069364,0.5734282395787608,1.0,35/117,20.22%,KCNN4;KCNQ1;CEACAM1;FLT4;ITGA1;FBXL2;ATP2B4;FOXO1;DAB2IP;IQGAP1;AKAP5;PPP1R16B;CTTNBP2NL;SHOC2;MFHAS1;HSP90B1;PTK2;STRN3;GRIN3A;ARPP19;CTNNB1;CDC27;ANK1;BOD1;RACK1;ANAPC7;STRN4;MAPK14;PPP1R16A;PPP1R9B;STRN;ANAPC4;PPME1;SMG7;JUP
prerank,poly(U) RNA binding (GO:0008266),-0.4967635874252455,-1.400695292280291,0.07758620689655173,0.5511087258419639,1.0,5/20,8.91%,RBMS3;RBMS1;HNRNPH1;SSB;DAZAP1
prerank,phosphatidic acid binding (GO:0070300),0.5980908943365748,1.3955657821766283,0.12691131498470948,0.5853807998685866,1.0,5/19,5.77%,RAPGEF2;PACSIN2;RAPGEF6;PLTP;UQCC3
prerank,low-density lipoprotein particle binding (GO:0030169),0.6224364335188765,1.394284218421053,0.121875,0.5818332604451201,1.0,2/16,5.63%,CDH13;PLTP
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.4379228468597322,1.3940503267806492,0.03225806451612903,0.5750640017220432,1.0,33/188,12.28%,PRDM16;SOX17;SOX13;GATA6;SMAD6;SMARCA2;TAL1;HNF1A;HNF4A;SOX18;HHEX;FLI1;KLF4;MAFK;MEF2C;ZBTB48;GATA3;CEBPA;NFE2L2;NR1D1;KLF11;JUN;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,FAD binding (GO:0071949),-0.47152986125433693,-1.3932056315481876,0.08359133126934984,0.5577705135134596,1.0,9/24,21.30%,MICAL3;MICAL2;DDO;PRODH;CRY2;SQLE;MICAL1;NDOR1;MTHFR
prerank,phosphoric ester hydrolase activity (GO:0042578),0.5011319804026173,1.390424855671632,0.09043927648578812,0.5793810030632432,1.0,12/49,10.01%,PTPRJ;DUSP12;ACP6;SMPDL3A;PRUNE1;APEX1;DUSP16;DUSP3;PTPRO;GDPD1;ENPP6;DUSP11
prerank,clathrin adaptor activity (GO:0035615),0.6149760672911665,1.3891094793097387,0.11596638655462185,0.5762494775465797,1.0,5/15,9.72%,HIP1;HIP1R;AP2B1;STON1;AP2M1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.5418458664190362,1.3888582968658074,0.1133879781420765,0.5701019500804849,1.0,9/32,17.87%,KCNQ1;KCNE3;KCNG3;KCNC1;KCNC4;KCNA1;KCNC2;KCNH1;KCNQ3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4226845481385627,1.3879494275128141,0.017745302713987474,0.5661334717560618,1.0,32/254,9.84%,PRDM16;MECOM;SOX17;ERG;CASZ1;NR4A2;FOXO4;FOXO1;ELK3;NR1I3;KLF7;IRF2;HNF1A;HNF4A;KLF6;SOX18;HHEX;KLF4;LEF1;MAFF;FOXF2;MEF2C;SMAD2;FOSL2;GATA3;ZBTB16;CEBPA;PLSCR1;JUN;TCF3;EGR1;PLAG1
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.6597435776260313,1.3875077884431346,0.11960132890365449,0.5605153839615422,1.0,2/12,6.38%,CDK19;MAPK1
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.636854491024007,1.3845008953845388,0.1433389544688027,0.5624182689821742,1.0,5/12,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,lipid phosphatase activity (GO:0042577),0.6222377032689875,1.3844898533169052,0.11745513866231648,0.5558591568123787,1.0,3/14,3.52%,SGPP2;PLPP1;INPP5K
prerank,ephrin receptor activity (GO:0005003),-0.5144593806088584,-1.3838120429217426,0.12716763005780346,0.5548734264860865,1.0,13/17,38.42%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.5144593806088584,-1.3838120429217426,0.12716763005780346,0.5548734264860865,1.0,13/17,38.42%,EPHA3;EPHA7;EPHB4;EPHB2;EPHB3;EPHA6;EFNB3;EPHB6;EPHA8;EFNA4;EFNA3;EPHA1;EPHA5
prerank,phospholipase inhibitor activity (GO:0004859),-0.5935982223628049,-1.3776443394355802,0.12705882352941175,0.5578516040334687,1.0,6/10,25.63%,ANXA2;ANXA1;ANXA5;ANXA4;ANGPTL3;ANXA9
prerank,protein phosphatase 1 binding (GO:0008157),0.5760251726694389,1.371877611496657,0.10869565217391304,0.5860190219203065,1.0,3/21,6.72%,KCNQ1;PPP1R16B;SHOC2
prerank,amyloid-beta binding (GO:0001540),0.4661397865237425,1.3690913727704679,0.08004778972520908,0.587405645449451,1.0,20/79,11.86%,FZD6;APBB2;APBA1;INSR;ATP1A3;CACNA1A;TGFB2;ADRB2;APOA1;FCGR2B;IAPP;PFDN6;ITGAM;VBP1;GRIA1;GRIN2B;PRNP;PFDN2;CLU;ACHE
prerank,cell adhesion mediator activity (GO:0098631),0.5569972881058257,1.364840114088732,0.1277860326894502,0.5938658097125833,1.0,11/24,20.90%,BCAM;ESAM;ROBO4;CD47;BSG;LRRC4C;MYPN;NPTN;DSCAM;CNTN4;CNTN6
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.6277717486575066,1.3633365335119707,0.13793103448275862,0.5914600568062119,1.0,1/13,0.28%,KCNQ1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5856835157915619,1.3629445815391819,0.1267605633802817,0.5859322751011594,1.0,5/18,4.11%,LTBP4;ENG;BMPR2;ACVRL1;ACVR1
prerank,phosphatidylinositol binding (GO:0035091),0.45764164032194393,1.3628922152782093,0.07032181168057211,0.579644035338935,1.0,23/91,13.74%,HIP1;MYO1E;ITPR3;HIP1R;ESYT2;FES;FCHO2;ING2;PLEKHF2;EPB41;SH3YL1;SNX10;MCF2L;PASK;PITPNA;CCDC88A;AIDA;EXOC8;NUMA1;SNX11;SNX22;ZFYVE9;SNX24
prerank,myosin V binding (GO:0031489),0.6176425258203422,1.358112606651307,0.14421553090332806,0.5864183387839559,1.0,2/15,2.22%,RAB11A;RAB6B
prerank,lipoprotein particle binding (GO:0071813),0.5863097063272384,1.3569391952743088,0.14242424242424243,0.5833015858260969,1.0,2/20,5.63%,CDH13;PLTP
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.6204362320960728,1.355496873785988,0.13095238095238096,0.5811153594580079,1.0,2/13,2.53%,PIP5K1B;PIK3C2A
prerank,chemorepellent activity (GO:0045499),0.5522719384998717,1.3517786265359915,0.12053571428571429,0.5857851768813657,1.0,4/25,4.67%,SEMA3G;SEMA3F;APOA1;SEMA7A
prerank,MHC class I protein binding (GO:0042288),0.6053973474771964,1.3476662301969615,0.15946843853820597,0.5920195371325236,1.0,5/13,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,mRNA 3'-UTR binding (GO:0003730),-0.3528844584546137,-1.345598553637243,0.06134969325153374,0.6422427726544889,1.0,26/79,19.01%,CELF2;RBMS3;RBMS1;DDX5;CPEB1;FXR2;NUDT21;HNRNPA2B1;PUM1;CSDC2;DAZAP1;GEMIN5;YBX3;CCT5;LARP4B;TARDBP;CPEB2;CPEB3;TUT1;PCBP4;HNRNPU;ELAVL3;LARP1;RC3H1;PABPC1;ZFP36
prerank,transforming growth factor beta binding (GO:0050431),0.5484412847324135,1.3452088764955932,0.1567732115677321,0.5928078320019753,1.0,6/23,5.33%,LTBP4;ENG;ACVRL1;ACVR1;WFIKKN1;HYAL2
prerank,AMP binding (GO:0016208),-0.5703054137553092,-1.345104875539464,0.1462140992167102,0.6275217445935192,1.0,2/11,0.60%,PRKAG2;MPPED2
prerank,semaphorin receptor binding (GO:0030215),0.5606344750433909,1.3411681054023659,0.1467065868263473,0.5977746688349349,1.0,3/23,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,protease binding (GO:0002020),-0.32962384479659124,-1.340198091177555,0.033783783783783786,0.6276928546157311,1.0,22/99,13.44%,COL1A2;COL3A1;COL1A1;CCBE1;BCL2;SLC2A13;ANXA2;ITGAV;PRKN;DPP4;TIMP2;NTRK2;LCOR;FAP;F3;BDKRB2;CFLAR;ADAMTSL4;SERPINE1;ATP9A;BFAR;ECM1
prerank,pre-mRNA binding (GO:0036002),-0.44288278178587215,-1.3377414241390797,0.10367892976588629,0.6206259012463377,1.0,11/28,24.12%,CELF2;DDX5;PRPF8;SRSF6;HNRNPL;HNRNPU;U2AF2;SLBP;CELF1;CELF5;U2AF1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.5583562750506519,1.3361439216404385,0.14939024390243902,0.60076464077258,1.0,2/21,2.26%,CDK19;CDK14
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.5583562750506519,1.3361439216404385,0.14939024390243902,0.60076464077258,1.0,2/21,2.26%,CDK19;CDK14
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.41979415818831417,1.3350946034801974,0.05652173913043478,0.597859312940298,1.0,25/173,11.01%,PRDM16;SOX13;KLF8;DACH1;ZFP69;ELK3;KLF12;HEY1;LRRFIP1;HHEX;HEY2;MAFK;GATA3;BCL6B;ZBTB16;GTF2IRD1;NR1D1;SNAI2;ERF;FOXP1;JUN;TCF3;ZBTB14;ZBTB34;DEAF1
prerank,antiporter activity (GO:0015297),0.5720960096826375,1.3334122510682607,0.1448170731707317,0.5969204683505347,1.0,6/20,9.52%,SLC25A16;ATP1A3;SLC35D2;SLC35E4;CLCN3;SLC25A30
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5406187808817606,-1.3320690654509073,0.16804407713498623,0.6250647329625277,1.0,6/12,16.69%,XDH;AOX1;FDX1;CIAPIN1;FXN;SDHB
prerank,metallopeptidase activity (GO:0008237),-0.3240973076944469,-1.330474356793247,0.023622047244094488,0.6153802464027658,1.0,28/113,13.35%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;PAPPA;ADAMTSL5;MMP14;ADAMTS17;ANPEP;ADAMTS5;ADAMTS10;ADAMTS3;ADAM19;ADAM9;ADAMTS15;ADAMTS9;PRPF8;MMP2;ADAM33;METAP1D;ADAMTSL4;MMP16;ZMPSTE24;MMP19;METAP1;ADAMTS14;RNPEP
prerank,N-acyltransferase activity (GO:0016410),0.5092214868728995,1.327887338789178,0.14730878186968838,0.606804079350563,1.0,6/32,9.27%,SATL1;CERS4;GLYAT;NMT1;CERS6;CERS5
prerank,phosphatase activity (GO:0016791),0.45616400319730244,1.326897487303032,0.09022556390977443,0.6038209662193371,1.0,19/73,16.64%,PTPRJ;ALPL;DUSP12;PLPP1;INPP5K;MINPP1;ACP6;PRUNE1;DUSP16;DUSP3;PTPRO;DUSP11;OCRL;PLPP6;PLPP4;DUSP28;DUSP26;PLPPR1;ARMT1
prerank,disordered domain specific binding (GO:0097718),0.5512624100304023,1.3256888134957336,0.14558823529411766,0.6013887084451376,1.0,7/23,12.72%,FYN;SMAD2;DFFB;GAPDH;NUMA1;CALM3;KCNA1
prerank,carboxy-lyase activity (GO:0016831),0.5479462638399035,1.3225536064654957,0.1337295690936107,0.6044131507158093,1.0,4/23,8.74%,AMD1;AZIN1;PCK2;ACOD1
prerank,ligand-gated calcium channel activity (GO:0099604),0.5554213532393116,1.3210205299010886,0.15569823434991975,0.6036490170632556,1.0,5/19,11.28%,ITPR3;MCOLN1;GRIN2B;GRIN2C;TRPM2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5328758779884866,-1.3207766353830224,0.13348946135831383,0.6317915497414848,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5125416916036334,-1.318961201175565,0.14824120603015076,0.6232241181822982,1.0,5/15,14.18%,SLC1A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.4686590229645087,1.3179173511494846,0.13020833333333334,0.6064968351749598,1.0,6/55,4.28%,ATP2A3;TRPV4;ATP2B4;ATP2B2;ATP2C1;ORAI1
prerank,GTPase activity (GO:0003924),0.4097607584934092,1.3173744368171996,0.04919786096256684,0.6025579026567851,1.0,47/192,16.69%,RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;KRAS;NRAS;RRAS;GNG3;ATL1;GBP3;RAB23;GNAI2;IRGM;LRRK2;RAB35;MMAA;RRAGD;RHEBL1;RRAS2;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;RAB19;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,PDZ domain binding (GO:0030165),0.46190095733347625,1.3146708481406273,0.12307692307692308,0.6046520455447635,1.0,19/61,14.82%,CCDC88C;RAPGEF2;F11R;ATP2B4;ATP2B2;TMEM88;CADM1;SNTG2;USHBP1;PLEKHA1;ADAM17;GRIA1;ACOX1;CLCN3;SLC22A5;GNG5;TBC1D10A;NSF;FZD3
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6264613808962685,1.310215749025853,0.1736842105263158,0.6064822704888004,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6264613808962685,1.310215749025853,0.1736842105263158,0.6064822704888004,1.0,2/10,6.26%,DUSP1;DUSP16
prerank,pyrophosphatase activity (GO:0016462),0.4704532071392609,1.3090788105039497,0.1453104359313078,0.6043892090857705,1.0,11/50,13.99%,ENTPD1;ALPL;PLPP1;PRUNE1;DCPS;DHX9;ADPRM;PRUNE2;TRPM2;PLPP4;NUDT9
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5893234242360301,1.3086952514282402,0.1848341232227488,0.6002294207518444,1.0,3/15,12.63%,CCR1;CMKLR1;CX3CR1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.40209007209818337,1.3081441949352357,0.04479166666666667,0.5964824102706513,1.0,60/248,16.69%,MYO1E;RND1;GBP5;GNAQ;RAB11A;RAB6B;ATL2;RHOB;GNAL;GBP4;DNM3;MTG2;GCH1;DDX4;KRAS;NRAS;KIF26A;RRAS;GNG3;ATL1;GBP3;MYH9;KIF2A;THTPA;RAB23;GNAI2;IRGM;LRRK2;HSPA1B;MYL6;RAB35;MMAA;DHX9;RRAGD;RHEBL1;RRAS2;ABCG4;GTPBP1;RAC1;MFN1;EEF2;GNG5;GBP2;CLU;RAB19;PIN1;RHOT2;RND2;GNB2;RHOH;RAN;RHEB;SRPRA;ARL8A;KIF1A;GNA14;EFL1;RAB27B;RIT2;GBP7
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.495153251628065,1.3030814729051576,0.15287517531556802,0.6055743380874573,1.0,5/34,3.63%,CYTH3;FCHSD2;HIP1R;IQGAP1;ARAP3
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.37416308803224724,-1.303063861178712,0.08520179372197309,0.6588431380179054,1.0,6/53,3.00%,SLC7A11;SLC1A3;SLC7A2;SLC47A1;SLC1A5;SLC25A13
prerank,sulfuric ester hydrolase activity (GO:0008484),-0.5347227884805056,-1.3025309521290114,0.16136919315403422,0.6465788040822594,1.0,4/12,6.60%,SULF1;SULF2;GNS;ARSI
prerank,ion channel inhibitor activity (GO:0008200),0.4953289003672059,1.3022035715258484,0.16246498599439776,0.6027324239829936,1.0,9/35,10.96%,FKBP1A;MCUB;VTI1B;STX7;CAMK2D;SLC30A1;VAMP8;SCN1B;NEDD4L
prerank,transmitter-gated ion channel activity (GO:0022824),0.5040334141079442,1.3020292519383718,0.18039772727272727,0.5981387789358029,1.0,15/29,26.34%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GLRA2;GABRG3;GABRB1;GRID2;GABRB3;GRIA2;GABRA3;GRIA4
prerank,insulin-like growth factor binding (GO:0005520),-0.5009225574825085,-1.3012177960413087,0.16180371352785147,0.6376998982540788,1.0,5/15,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,heme binding (GO:0020037),0.45335200820845123,1.2978391335017505,0.13740458015267176,0.6046106226426939,1.0,6/65,9.30%,NOS1;NOS3;JAK2;HEBP1;NR1D1;HMOX2
prerank,SH2 domain binding (GO:0042169),0.5068291180809305,1.2964974039987804,0.1676056338028169,0.6034219386329888,1.0,8/31,10.33%,AFAP1L2;TRPV4;CRK;NLK;ARHGAP5;JAK2;PTK2;CCDC88A
prerank,kinase binding (GO:0019900),0.38919630338498734,1.2943491378974585,0.016210739614994935,0.6043802612788709,1.0,91/435,16.29%,PTPRJ;PLCG2;TRPV4;GATA6;PTPRR;UTRN;CEACAM1;TRIM14;FAS;CCND2;RND1;ACVRL1;NOD2;CCND3;ATP1A4;DAB2IP;TTC28;CAV1;CAV2;RHOB;OXSR1;EMP2;IQGAP1;HDAC7;BTG1;CRK;FBXO7;MSN;NBEA;TRIM6;BCAR3;SIKE1;CDC25C;WARS1;SMCR8;ADIPOR1;CEP68;DUSP3;IRGM;HNRNPA0;ELAVL1;HSPB1;PDE8A;MAPRE3;CEBPA;BCL2L1;TOM1L1;JAK2;WWC2;APC;STAP1;PTK2;ADAM10;CASP1;PLCG1;NEFH;PTPN1;RAC1;TPCN2;POLA1;CADPS;ACTB;NPM1;EEF2;PIK3IP1;VRK1;CALM3;IRF5;CTBP2;PRC1;INKA1;RND2;CNKSR2;HIF1A;AP1B1;RHOH;NSF;LYST;CTNNB1;LRBA;KIZ;FRMD5;PDCD10;CDKN2D;PAK2;VDAC1;RICTOR;NEK9;PFKM;SGO1;ESR1
prerank,calcium channel inhibitor activity (GO:0019855),0.6185493461363554,1.2932773738833154,0.2061328790459966,0.6022903627998497,1.0,3/11,7.19%,FKBP1A;MCUB;SLC30A1
prerank,glycerophospholipid flippase activity (GO:0140333),0.6307056248505981,1.2923649623293605,0.18360655737704917,0.599733137017037,1.0,4/11,12.78%,ATP10A;ABCB4;ATP11C;ATP8B1
prerank,receptor ligand activity (GO:0048018),0.3978109894601552,1.2914664467996018,0.0505795574288725,0.5973908054566733,1.0,14/245,4.67%,VEGFC;SEMA3G;JAG1;JAG2;EDN1;PDGFB;KITLG;DAND5;TGFB2;SEMA3F;TAFA1;APOA1;VEGFD;SEMA7A
prerank,GTP binding (GO:0005525),0.40414394429904776,1.2910153985940842,0.05984766050054407,0.5938174952060304,1.0,43/172,16.73%,RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,double-stranded RNA binding (GO:0003725),0.4436131055238955,1.2876945657184558,0.1281437125748503,0.5977114164836141,1.0,16/70,13.08%,ADARB1;IFIH1;LRRFIP1;VIM;TLR3;MSN;MBNL1;TUBB4B;ELAVL1;ZNF346;OAS2;ADAR;DHX9;AGO4;ILF2;FXR1
prerank,carbohydrate kinase activity (GO:0019200),-0.5330295524103511,-1.2853882507173318,0.1585081585081585,0.6722115961857958,1.0,5/11,21.12%,GALK2;HK2;NAGK;GALK1;POMK
prerank,histone acetyltransferase activity (GO:0004402),-0.41287037524833714,-1.2847144401709085,0.11627906976744186,0.6608993158183039,1.0,14/30,23.28%,TADA2A;CREBBP;KAT2B;TAF1;HAT1;CLOCK;USP22;ATF2;NAA60;TADA3;NAA40;MCM3AP;TAF10;NAA50
prerank,I-SMAD binding (GO:0070411),0.5823526679090739,1.2841281369869602,0.19047619047619047,0.6022222030014894,1.0,5/13,14.25%,SMAD6;SMAD7;SMAD2;SMURF1;CTNNB1
prerank,glucose transmembrane transporter activity (GO:0005355),0.560526155305324,1.2839643333364836,0.18459069020866772,0.5979226044329253,1.0,2/17,3.02%,SLC2A1;SLC5A10
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5017817611754039,1.2829224064690528,0.17758369723435224,0.596299658067048,1.0,9/28,19.60%,GRID1;GABRA4;GRIK5;GRIK2;GABRA2;GABRE;GRIK1;GABRG3;GRID2
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.5122597563354429,-1.2819426363665583,0.17587939698492464,0.657452443266452,1.0,8/12,22.79%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;LARP1;NCBP3;NCBP2
prerank,potassium ion antiporter activity (GO:0022821),-0.49998221218870814,-1.2812631969412724,0.1585014409221902,0.6472604011715831,1.0,3/15,6.64%,SLC24A3;SLC9A2;SLC9A9
prerank,insulin-like growth factor I binding (GO:0031994),-0.5136624746583229,-1.2743595533980543,0.20100502512562815,0.6560414058634003,1.0,5/13,7.26%,IGFBP5;IGFBP2;IGFBP6;ITGAV;IGFBP3
prerank,protein serine/threonine kinase activity (GO:0004674),0.39041108939964037,1.2740648340184082,0.04405737704918033,0.6142465030154872,1.0,67/335,12.94%,NUAK1;CDK19;KALRN;MAP4K2;STK10;BMPR2;RPS6KA5;PLK3;ACVRL1;MAP4K3;MYLK;SBK1;CDK14;SNRK;PRKD1;MAST4;OXSR1;CDC42BPA;TRIO;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;SLK;STK24;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;IRAK2;MAPK1;UHMK1;MAST1;AKT3;SIK2;LRRK2;LMTK2;TLK1;STK19;PRKAA1;STK39;PASK;PIM3;NEK7;ROCK1;CSNK1G3;SGK1;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;NEK11;PRKD2;MARK2;VRK1;TTBK1;STK33;RPS6KA3;RPS6KB1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.3568352934827322,-1.2732929265915733,0.08403361344537816,0.646854855393535,1.0,14/55,10.93%,SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC6A12;SLC16A6;SLC16A9;SLC38A11;SLC19A1;SLC22A4;SLC38A10;SLC38A5;SLC16A11
prerank,calcium ion binding (GO:0005509),0.3897997197944355,1.2720566883316147,0.04285714285714286,0.6150863977507451,1.0,44/323,11.44%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;AOAH;CALML4;AGRN;CEMIP2;IQGAP1;ANXA3;SYT7;SLC8A1;NUCB2;SPOCK2;STIM2;MEX3B;TPD52;ASAH2;EFCAB9;PPP3CA;HSP90B1;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;DSPP;CDH12;DHH;PRNP;CDH2;SPOCK1;TRPM2;PCP4
prerank,DNA-binding transcription factor binding (GO:0140297),0.3999822689184055,1.2714198225779705,0.09609292502639916,0.612050482413774,1.0,30/189,11.54%,PRDM16;LDB2;LMO2;FOXO4;TBXT;TAL1;HNF4A;HDAC9;HDAC7;HHEX;RBBP8;HEY2;KLF4;MEF2C;SMAD2;BBS7;CHCHD2;STAT1;HSPB1;PURA;RBL1;NFE2L2;JUN;TCF3;HMGB1;DHX9;MAD2L2;CRTC1;NPM1;DMAP1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.594102820873026,1.2678891557167626,0.21143847487001732,0.6172655041837569,1.0,2/11,4.58%,GATA2;LEF1
prerank,GABA-A receptor activity (GO:0004890),0.5462860172560886,1.266918404645963,0.2033898305084746,0.6152081696119304,1.0,7/18,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,adenylate cyclase binding (GO:0008179),-0.5420826264201828,-1.2639873010289604,0.18691588785046728,0.6638932046774062,1.0,4/10,7.03%,ADCY5;AKAP12;ADCY2;CALM2
prerank,channel activity (GO:0015267),0.46198586677468667,1.2596855747513354,0.17408906882591094,0.6307842584949779,1.0,3/41,2.74%,TRPV4;AQP11;MCUB
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.5771366057013891,1.2591992968746997,0.21247892074198987,0.6275135059537142,1.0,9/12,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3;GABRA3;GABRB2;GABRA5
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.43613221262057683,1.2588381441366079,0.14522292993630573,0.6239475829993615,1.0,10/72,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,myosin binding (GO:0017022),0.4540901523423716,1.2579718713012553,0.1625806451612903,0.6216390428029335,1.0,14/55,16.81%,MYRIP;SHROOM4;MYBPC3;RAB11A;RAB6B;SPATA6;LMTK2;NKD2;SHROOM1;CXCR4;RAB27B;STXBP5L;PYCARD;STXBP5
prerank,transcription cis-regulatory region binding (GO:0000976),0.3817536262044156,1.257249410725014,0.042682926829268296,0.619110230603887,1.0,58/406,12.28%,PRDM16;EPAS1;SOX17;SOX13;GATA6;SMAD6;MSX1;DACH1;SMARCA2;CASZ1;ZFP69;ELK3;NR1I3;TAL1;IRF2;HNF1A;HNF4A;SOX18;HHEX;ACTN4;FLI1;KLF4;SIM2;LEF1;MAFK;ZBTB46;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;SETX;PURA;RBL1;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF3;EGR1;HMGB1;ARID5A;ZBTB14;XRN2;DEAF1;NPM1;PHOX2A;E2F7;BRCA1;ARID5B;SOX10;HINFP;SOX6;SUV39H2
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.5228735346313977,-1.2554614255450127,0.1932367149758454,0.6772108136229135,1.0,3/11,7.11%,SLC25A47;SLC25A20;SLC22A4
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.5292870045409181,-1.2552407244173331,0.18872549019607843,0.6549289125656383,1.0,5/11,23.63%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,adenyl nucleotide binding (GO:0030554),-0.5292870045409181,-1.2552407244173331,0.18872549019607843,0.6549289125656383,1.0,5/11,23.63%,SIL1;BAG1;BAG3;GRPEL2;BAG2
prerank,translation elongation factor activity (GO:0003746),0.5665425249238853,1.2547533434688813,0.1847649918962723,0.6213085384116156,1.0,8/14,26.99%,TUFM;GTPBP1;EEF2;GTPBP2;EEFSEC;GFM1;TSFM;EEF1A1
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.43709839985854304,-1.2506204786876691,0.1755485893416928,0.6566308794169796,1.0,10/22,21.35%,IKBKE;TAB3;OPTN;PRPF8;OTUD7B;WDR81;ZRANB1;TNFAIP3;ZRANB3;RNF168
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.4081992176673716,1.24630847547928,0.148711943793911,0.6400310644074484,1.0,26/100,18.31%,CYTH3;FCHSD2;HIP1;HIP1R;DAB2IP;TTPA;IQGAP1;ARAP3;TECPR1;CERT1;PLEKHA5;MYO10;SNX11;SAP30L;SNX22;BTK;SNX24;PHLDA3;RUBCN;CLVS1;KIF16B;ZFYVE16;ARFIP2;KCNH1;GOLPH3L;GOLPH3
prerank,alkali metal ion binding (GO:0031420),-0.5123117306543987,-1.2455874154046664,0.18848167539267016,0.6598562635621195,1.0,5/13,14.70%,ATP1A2;PDXK;ADPRH;HDAC4;DRG1
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.36188033986835144,-1.2420622611823453,0.14285714285714285,0.6595661124364258,1.0,10/47,7.99%,SLC7A11;SLC6A13;SLC7A2;SLC47A1;PDPN;SLC1A5;SLC38A11;SLC6A1;SLC22A4;SLC38A10
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.462379490409038,-1.2403024088527352,0.18087855297157623,0.6537339271503761,1.0,8/16,22.39%,SLC13A3;SLC1A5;SLC25A13;SLC1A4;SLC25A12;SLC25A18;SLC25A14;SLC13A5
prerank,chemokine receptor activity (GO:0004950),0.5124112148536745,1.240162211772701,0.20058997050147492,0.6526311965623224,1.0,4/24,14.74%,CCR1;CMKLR1;CX3CR1;CXCR4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.44468955578649905,1.2383551529024552,0.15649867374005305,0.653077431118215,1.0,7/54,6.37%,ACER2;HDAC9;GLS2;GLS;HDAC11;ASAH2;SIRT4
prerank,cGMP binding (GO:0030553),0.5755998768460312,1.2354293884552074,0.2376237623762376,0.6569566758637138,1.0,1/11,0.63%,RAPGEF2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.35580361312072845,-1.2340100555789797,0.13127413127413126,0.6610908334147738,1.0,12/48,11.67%,TRPM3;NALCN;PIEZO2;SLC12A2;SLC41A1;TRPM6;ATP6V1B2;ABCC9;TRPC6;DMAC2L;CALHM5;TRPV2
prerank,potassium ion leak channel activity (GO:0022841),-0.4630416860577402,-1.2336842602986597,0.20580474934036938,0.6517578781529527,1.0,2/15,2.94%,KCNK2;KCNK5
prerank,nuclear receptor coactivator activity (GO:0030374),-0.342592308361068,-1.2322650873876257,0.14655172413793102,0.6455793079552277,1.0,16/52,13.95%,PPARGC1B;ZMIZ1;PRKCB;TACC1;CCAR1;FGF2;MED13;RNF4;MED14;RBM14;CCDC62;CALCOCO1;ZMIZ2;USP22;ATXN7L3;ELK1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5265920924572903,1.2299646542677571,0.21559633027522937,0.6679778910676561,1.0,6/18,18.52%,TNFAIP8;RPS6KA1;RPS6KA3;NOL3;VIL1;XIAP
prerank,SUMO transferase activity (GO:0019789),-0.46075120318323665,-1.2273475112463428,0.22636103151862463,0.6491965320340096,1.0,8/16,27.52%,PIAS3;HDAC4;CBX4;MDM2;TOPORS;PIAS4;UBE2I;NSMCE2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5113893008906136,-1.227297965676889,0.23897911832946636,0.639741914608277,1.0,4/11,20.68%,PPP1R1A;PPP1R14B;PPP1R2;PPP1R11
prerank,microtubule binding (GO:0008017),0.37751149886382407,1.222693792953686,0.12882787750791974,0.6844457585960365,1.0,52/222,15.66%,CCDC88C;TRPV4;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;MACF1;SAXO1;MAP4;DNM3;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;TTBK2;CAMSAP2;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;MAPRE3;HOOK1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;REEP3;PRC1;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;KIF16B;KIF1A
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5217628427403914,1.2223878405955533,0.21875,0.6805553513582389,1.0,8/17,17.26%,GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.5244495456915083,-1.2147878066173272,0.2564705882352941,0.6655402595936315,1.0,2/10,7.47%,B3GALT1;B4GALT1
prerank,Toll-like receptor binding (GO:0035325),0.5702818666390173,1.21449545069462,0.25426621160409557,0.6985806069491031,1.0,2/11,3.82%,DAB2IP;TIRAP
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.49316028163001413,-1.2129618240705335,0.24456521739130435,0.6614923741845155,1.0,6/12,18.56%,SHC1;IRS1;PIK3R1;SH2B1;GAB2;SH2B2
prerank,ligand-gated channel activity (GO:0022834),0.47021733560859763,1.2100138670654268,0.2369186046511628,0.7063531054803271,1.0,11/29,19.60%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.598350140956156,1.208845290344843,0.2866779089376054,0.7050435990442165,1.0,3/10,8.80%,APEX1;EXD2;FEN1
prerank,tRNA methyltransferase activity (GO:0008175),0.5365509990958692,1.2085278378750697,0.25990491283676703,0.7012170659266287,1.0,5/16,11.12%,TRDMT1;TRMT5;METTL2A;METTL2B;ALKBH8
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.47529300200517144,1.2034278098763782,0.23132183908045978,0.7109694823087682,1.0,15/30,28.79%,TNFAIP8;PTTG1;RPS6KA1;SPOCK1;RPS6KA3;NOL3;VIL1;CST3;XIAP;UBE2O;CARD16;SNCA;SERPINB9;PRDX5;CD27
prerank,guanyl ribonucleotide binding (GO:0032561),0.3732278510672985,1.2033814272596144,0.14316239316239315,0.7064377696425568,1.0,44/196,16.73%,RAPGEF2;RND1;GBP5;INSR;ATL2;RHOB;GBP4;MTG2;GCH1;KRAS;NRAS;SCG5;RRAS;RAB39A;TUBB;GLUD1;ATL1;GBP3;TUBB4B;MFHAS1;LRRK2;RAB35;MMAA;EIF2B2;TUBA8;ARF3;RRAGD;RHEBL1;RRAS2;RAC1;GBP2;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;ARL8A;ARL5B;RAB27B;RIT2;GBP7;ARFIP2
prerank,ligand-gated ion channel activity (GO:0015276),0.4666084418841114,1.201563941630382,0.23357664233576642,0.7069412664295456,1.0,11/30,19.60%,GRID1;GRIA1;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;GRIK1;GRIN2A;GABRB1;GRID2
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.38411300383888225,-1.2001908679311515,0.1935483870967742,0.6881748699296454,1.0,14/33,16.42%,SCAF8;RRN3;PAF1;ERCC5;ERBB2;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;MAF1;WAC
prerank,RNA cap binding (GO:0000339),-0.44462848166758956,-1.1999321395764815,0.21505376344086022,0.6794312898767225,1.0,9/16,18.58%,CYFIP2;EIF4E2;NCBP1;EIF4E3;GEMIN5;EIF3D;SNUPN;LARP1;NCBP3
prerank,flavin adenine dinucleotide binding (GO:0050660),0.43083490516670614,1.1998714908570387,0.22538860103626943,0.7072109446208521,1.0,6/53,8.17%,NOS1;NOS3;CYB5R1;ETFDH;ETFA;ACOX1
prerank,calcium channel activity (GO:0005262),-0.3129071385961936,-1.198637433710809,0.1282051282051282,0.6739681275007072,1.0,16/84,12.40%,SLC24A3;CACNA2D3;CACNA1C;ANXA2;TRPC3;ITGAV;CACNG4;CACNA2D1;P2RX4;NCS1;TRPC6;TRPC4;CACNB1;PKD1;TRPV2;CACNB2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.44719777249605,1.1966406330908739,0.24426450742240216,0.711793690232904,1.0,4/42,4.81%,CCNY;CCND2;CCND3;CCNE1
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4245457816591781,1.1964332964060709,0.2125,0.7078522078520675,1.0,11/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;ACVRL1;INSR;ACVR1;FGFR3;ALK;LMTK2
prerank,mannose binding (GO:0005537),-0.480725151675207,-1.1931638934293285,0.25,0.6801281715071208,1.0,8/12,46.02%,LMAN1;CLN5;LMAN2;ACR;COLEC11;LMAN2L;LMAN1L;CLEC4D
prerank,tubulin binding (GO:0015631),0.36053934619131855,1.1908259338774958,0.13594232749742532,0.7186913781074995,1.0,65/296,15.66%,CCDC88C;TRPV4;STMN2;FYN;RABGAP1;IRAG2;MTUS1;RAB11A;EML1;ARHGEF2;SAXO1;MAP4;DNM3;TTLL7;CLIP2;DST;KIF26A;VASH2;MAP4K4;FAM161A;EML6;PRUNE1;PHF6;GABARAPL1;CLIP1;KIF2A;CLASP1;MAST1;WHAMM;LRRK2;VBP1;MAPRE3;HOOK1;TTLL1;REEP2;STARD9;APC;CCDC181;GAPDH;UXT;GAS2L3;CLASP2;PRNP;CCDC88A;NEFH;POLB;REEP1;NUMA1;BRCA1;DIP2B;TTLL5;REEP3;TTLL11;PRC1;RAD51D;EFHC2;KIF26B;MAP1LC3A;NAV3;SYBU;VAPA;MAP2;ARL8A;KIF16B;KIF1A
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5083330412111509,-1.1904277399189993,0.2535885167464115,0.6783754729361833,1.0,2/10,3.22%,SLC24A3;SLC8A3
prerank,R-SMAD binding (GO:0070412),0.49938811922164084,1.1897804947279618,0.27416798732171155,0.7173783954782933,1.0,9/18,19.63%,SMAD6;SMAD2;JUN;PMEPA1;SMURF1;DROSHA;MEN1;SMAD4;TRIM33
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.5329146274441005,1.185159681633218,0.2912621359223301,0.7259732860902421,1.0,7/13,26.49%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRA3;GLRB
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.45060604157508005,-1.1845722833495478,0.24225352112676057,0.686602486712964,1.0,17/18,54.99%,HSD17B8;HSD11B1;HSD17B10;HSD17B2;HSD3B7;HSD17B14;HSD17B1;DHRS11;HSD17B7;SRD5A2;HSD3B2;AKR1C1;DHRS9;RDH16;HSD17B6;HSD17B3;RDH5
prerank,GTPase regulator activity (GO:0030695),0.36802226083469763,1.1838177463013595,0.173036093418259,0.7251663518172339,1.0,49/212,13.95%,PREX2;RAPGEF2;ARHGAP31;RGS3;PLCB1;RABGAP1;SIPA1L2;CHN2;GNAQ;ABR;ASAP2;IQGAP1;SIPA1L3;RALGAPA1;ARAP3;BCR;TBC1D30;SGSM1;ARHGAP8;TBC1D8;RAP1GDS1;SH3BP4;RGS7;RAB3GAP2;LRRK2;RANGAP1;ARHGAP25;TBC1D12;ARRB1;TBC1D5;TBC1D1;JUN;RAP1GAP2;CCDC88A;RANBP2;RANBP1;RALGAPB;OCRL;ARHGAP27;DOCK1;ITGB1BP1;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RHOH;RGS12;RALGAPA2;SOS1
prerank,cation channel activity (GO:0005261),-0.29562348839895297,-1.1775523003826305,0.12658227848101267,0.6974715150403089,1.0,11/94,6.36%,SLC24A3;TRPM3;NALCN;PIEZO2;KCNK5;ANXA2;TRPC3;ANO1;TRPM6;ABCC9;KCNQ4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.49451363825839695,1.1756562517836686,0.2841269841269841,0.7435093192673407,1.0,2/22,3.89%,ATP2A3;ATP2C1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.5629120335712255,1.17399734367521,0.2972027972027972,0.7436735186466826,1.0,4/10,17.50%,GABRA4;GABRA2;GABRE;GABRG3
prerank,anion channel activity (GO:0005253),0.412903899722121,1.1726689343599526,0.2600502512562814,0.7430121358776928,1.0,16/61,19.81%,LRRC8C;CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;GABRA4;GABRA2;GABRE;VDAC1;GLRA2;GABRG3;GABRB1;VDAC3;CLCN7
prerank,galactosyltransferase activity (GO:0008378),0.5738986515696803,1.1717004880650195,0.313588850174216,0.7411902053770999,1.0,4/11,14.64%,B4GALT4;A4GALT;B4GALT6;A3GALT2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.43788503725491706,-1.1707603423682988,0.24685138539042822,0.6989532445953748,1.0,6/16,16.44%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.43788503725491706,-1.1707603423682988,0.24685138539042822,0.6989532445953748,1.0,6/16,16.44%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP5F1B;ATP6V1A
prerank,sodium:proton antiporter activity (GO:0015385),-0.4839264500698536,-1.1690300248809735,0.29770992366412213,0.6954125190221565,1.0,5/11,19.39%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.373722816061553,-1.1689643501897145,0.23125,0.6869693768488916,1.0,8/29,16.08%,PRKAG2;KAT2B;SPRED1;SPRED2;PRKAR2A;PRKAR2B;PRKAR1A;CDKN1A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.34966894997661985,1.167252407334507,0.10030090270812438,0.7495255628231243,1.0,81/597,13.59%,PRDM16;SOX17;SOX13;ERG;IRF6;GATA6;GATA2;SMAD6;MSX1;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;IRF2;ZNF296;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;MAFF;MEF2C;ZBTB48;GATA3;BCL6B;RXRG;ORC3;CEBPA;NFE2L2;NR1D1;SNAI2;KLF11;FOXP1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ARID5A;ZBTB14;POLA1;PHOX2A;E2F7;BRCA1;NR4A1;ARID5B;KLF13;SOX10;ORC5;HINFP;SOX6;TLX3;SUV39H2;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5597395248996444,1.166117342050485,0.29187396351575456,0.7481963354076693,1.0,4/10,9.23%,IZUMO1;CD47;CD200;DSP
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.4837042129953685,1.1656391596131523,0.2709867452135493,0.7451118662911302,1.0,6/23,15.50%,HIP1;HIP1R;PLEKHA5;PHLDA3;CLVS1;KIF16B
prerank,organic anion transmembrane transporter activity (GO:0008514),-0.2802407881747012,-1.164878685202366,0.16037735849056603,0.6896116977281015,1.0,23/134,8.85%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A3;PDPN;SLC26A7;SLC1A5;SLCO2B1;SLCO3A1;SLC26A2;SLC25A13;GJA1;SFXN2;SLC39A8;SLC22A6;SLC6A1;SLC19A1;SLC52A1;SLC6A9;SLC27A1;MPC2;SLCO2A1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.37875503903583146,-1.1615274015005983,0.25806451612903225,0.6898060080662186,1.0,5/26,10.92%,B3GALT1;B3GNT2;GBGT1;CHPF2;EXTL2
prerank,ligand-gated anion channel activity (GO:0099095),0.49769163754224827,1.1598335025435962,0.29127725856697817,0.7567972260328583,1.0,11/17,30.69%,GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;GABRB3;GABRA3;GLRB;GABRB2;GABRA5
prerank,CoA-ligase activity (GO:0016405),0.5294098287828917,1.1565886717527878,0.30272108843537415,0.7615802426061798,1.0,5/14,14.79%,ACSM3;ACSBG1;ACSS2;AACS;SLC27A2
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.38136760566819716,-1.1553982031194105,0.2367601246105919,0.6991328090564412,1.0,10/27,22.42%,SLC41A1;SLC8A3;SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC8A2;SLC9A6;KCNK1;SLC4A8
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.35272594769190296,1.1548642736836185,0.18209876543209877,0.761951607532782,1.0,54/269,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;SUMO3;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;STAT1;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;DTX3L;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,gamma-tubulin binding (GO:0043015),-0.39493339284091367,-1.153878417321334,0.26409495548961426,0.6951699942266266,1.0,9/22,21.28%,BRSK1;TUBGCP4;DIXDC1;OFD1;DDX3X;NDRG1;TUBGCP5;BLOC1S2;RACGAP1
prerank,RNA methyltransferase activity (GO:0008173),0.4913789278233179,1.152726463801761,0.31851851851851853,0.7634055185636851,1.0,7/19,22.51%,TRDMT1;MRM2;TRMT5;FBLL1;FTSJ3;METTL4;FBL
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3880524675043562,1.1524899122903107,0.24939172749391728,0.7596150945262663,1.0,10/91,4.08%,KCNQ1;HIP1;PLCB1;HIP1R;STXBP6;TTPA;FLII;SYT7;TIRAP;FCHO2
prerank,calcium channel regulator activity (GO:0005246),0.43873687669310885,1.1499485725760903,0.2913165266106443,0.7624775927142526,1.0,6/37,9.30%,PRKG1;FKBP1A;MCUB;STIM2;SLC30A1;SGK1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.5442121765588257,1.1489853908606327,0.33447098976109213,0.7609337761598015,1.0,5/11,16.66%,CASP8;CASP2;CASP1;CASP7;PYCARD
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.49418904731721724,-1.1446135276730034,0.3032581453634085,0.7118637216510209,1.0,1/10,0.45%,DPYSL3
prerank,histone acetyltransferase binding (GO:0035035),0.4783163313923259,1.1428433448777466,0.2974588938714499,0.7740497791900383,1.0,5/21,15.06%,EPAS1;STAT1;EGR1;HIF1A;KANSL1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3499882483367604,1.142825024745729,0.21302998965873837,0.7697540316055678,1.0,51/254,14.74%,FZD6;SMAD6;ASB4;SMAD7;FOXO1;CASP8;HERC2;FBXO7;SUMO2;TUBB;GPI;NLK;SMAD2;TRAF1;TNFRSF1B;ARIH1;CUL3;GABARAPL1;ARRDC1;UBE2D1;MFHAS1;MC4R;HSPA1B;PRR5L;ARRB1;UBA52;APC;ACTG1;RPS27A;JUN;RTN4;FBXW7;RBX1;CUL2;NKD2;NFKBIA;BAG6;LAPTM5;CCT2;SNCAIP;BRCA1;TMBIM6;CLU;UBE2T;YOD1;UBE2J2;HIF1A;UQCRC1;MAP1LC3A;RAD18;CXCR4
prerank,potassium channel activity (GO:0005267),0.38398000887077555,1.141450335637658,0.2681498829039813,0.769278575455749,1.0,17/89,17.87%,KCNN4;KCNQ1;KCNH8;KCNG3;KCNK12;KCNC1;KCNH7;GRIK5;GRIK2;KCNK9;KCNC4;KCNA1;GRIK1;KCNC2;KCNH5;KCNH1;KCNQ3
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5217689905511329,1.1407492305441698,0.314785373608903,0.7670751200984318,1.0,5/14,11.08%,RECK;SPOCK2;TIMP3;SPOCK3;SPOCK1
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.3549910380402511,-1.1407419080499268,0.26785714285714285,0.7140199009909094,1.0,8/35,7.53%,MPPED2;PLCE1;PLCL1;ENPP1;ENPP3;NAPEPLD;PLCB3;GPLD1
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.533288741166964,1.1382296224345736,0.3338533541341654,0.7698931943017981,1.0,2/12,8.59%,RRH;ELOVL4
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.35781163797004245,-1.1342209740155578,0.27007299270072993,0.7240992477443118,1.0,15/32,24.20%,KDM7A;EGLN3;FTO;TET2;P4HTM;TET1;KDM4A;TMLHE;RIOX2;JMJD4;KDM8;PHF8;PHYHD1;BBOX1;PHYH
prerank,endopeptidase activator activity (GO:0061133),0.5353200180905121,1.1279410252195068,0.3452991452991453,0.794396414592438,1.0,4/10,20.86%,APH1A;VSIR;PSMD14;APH1B
prerank,endodeoxyribonuclease activity (GO:0004520),0.4735621789290734,1.1278155441588924,0.31859756097560976,0.790429551167938,1.0,6/20,14.21%,RBBP8;APEX1;ENDOV;FEN1;ERCC4;EXOG
prerank,hexose transmembrane transporter activity (GO:0015149),0.5250269738958122,1.1269239268174183,0.3222591362126246,0.7886079405436789,1.0,1/12,1.22%,SLC2A1
prerank,metal ion binding (GO:0046872),0.34029732917445626,1.1232078330642323,0.1881287726358149,0.7946254667608217,1.0,70/477,12.46%,CDH13;LTBP4;NOTCH4;SYT15;RAPGEF2;ITPR3;PITPNM3;MCTP1;DYSF;PLSCR4;ESYT2;EML1;CLGN;RASGRP2;SNRK;AOAH;CALML4;OXSR1;CDC42BPA;AGRN;CEMIP2;IQGAP1;MAP3K6;ANXA3;SYT7;CDC42BPG;SLC8A1;NUCB2;SPOCK2;PIR;STK38;STK38L;NLK;STIM2;MEX3B;TPD52;ASAH2;APEX1;EFCAB9;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;PPP3CA;HSP90B1;MT2A;MTPAP;CASQ1;PLSCR1;CDH15;CDH3;CRACR2A;FEN1;DSPP;CDH12;DHH;HSPE1;PRNP;CDH2;SPOCK1;TRPM2;XXYLT1;PCP4;TESMIN;GSS;MARK2;CALM3;TPM4
prerank,C-C chemokine receptor activity (GO:0016493),0.4687241552369469,1.1213299144093254,0.3368421052631579,0.7956471704240645,1.0,3/21,14.74%,CCR1;CX3CR1;CXCR4
prerank,glutamate receptor activity (GO:0008066),0.47616981854482887,1.1211337994213169,0.32701421800947866,0.7918588709197507,1.0,9/19,22.79%,GRID1;GRIA1;GRIK5;GRIK2;GRM5;GRIK1;GRM7;GRID2;GRIA2
prerank,sequence-specific DNA binding (GO:0043565),0.3360139596459972,1.1199915436461205,0.17002012072434608,0.7908432050303157,1.0,77/590,13.59%,PRDM16;EPAS1;SOX13;ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;HHEX;FLI1;HEY2;HMBOX1;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;GATA3;BCL6B;RXRG;CHCHD2;NFE2L2;NR1D1;SNAI2;ERF;KLF11;FOXP1;MBD1;KMT2B;JUN;TCF7L1;STN1;EGR1;ARID5A;ZBTB14;TET3;PHOX2A;E2F7;NR4A1;KLF13;SOX10;CHTOP;TLX3;IRF5;ELF2;CBFB;TGIF1;POU3F2;ZNF32;UNCX;TBX20;HIF1A;NFATC1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.4695796327244226,1.117040471282913,0.3192771084337349,0.7948257884572304,1.0,4/21,12.92%,KCNQ1;AKAP5;WASF2;AKAP1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.45528943143798606,-1.1148210275205976,0.36528497409326427,0.77075322955078,1.0,5/12,19.39%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,actinin binding (GO:0042805),0.47069704874801943,1.1136161383221779,0.34508076358296624,0.8000660454689805,1.0,4/21,4.79%,MAGI1;PROM1;PDLIM5;CSRP2
prerank,ankyrin binding (GO:0030506),0.4866490707237079,1.1117885394897689,0.3570274636510501,0.8009498067765234,1.0,4/19,7.89%,RHCG;SLC8A1;PLEC;NRCAM
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.3342201351826657,1.111406658260324,0.23910840932117527,0.797878580423089,1.0,93/431,16.73%,MAP4K2;RPS6KA5;RND1;GBP5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;ATL2;RHOB;OXSR1;CDC42BPA;SYN3;GBP4;MAP3K6;MTG2;GCH1;CDC42BPG;KRAS;NRAS;ACVR1;SCG5;ATP7A;RRAS;RAB39A;MAP4K4;STK38;TUBB;STK38L;NLK;GLUD1;ATL1;GBP3;MYH9;PGK1;PXK;TUBB4B;UHMK1;MAST1;P2RX7;AKT3;MFHAS1;SIK2;LRRK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;RAB35;CAD;MMAA;EIF2B2;TUBA8;MLKL;DHX9;ARF3;TAP1;RRAGD;RHEBL1;RRAS2;MINK1;RAC1;ABCC6;GBP2;NEK11;GSS;MARK2;BTK;VPS4A;RHOT2;RND2;TUBA1A;RRAD;RHOH;RAN;RHEB;MAP3K20;PANK3;RRM1;ARL8A;ARL5B;PFKM;RAB27B;P2RY1;RIT2;GBP7;ARFIP2
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.4766363297074038,1.111325266831547,0.34231378763866877,0.793931966063106,1.0,3/18,4.46%,STXBP6;CDC42EP1;PDLIM5
prerank,protein homodimerization activity (GO:0042803),0.3318537397741302,1.1108195212327665,0.193,0.7912281301817184,1.0,87/590,12.46%,PECAM1;FBLN5;HIP1;CEACAM1;RASIP1;STK10;PDGFB;TRIM14;FLT4;SYNE1;HIP1R;F11R;TBX1;NOD1;GBP5;B2M;IZUMO1;RBPMS;DAB2IP;CAV2;TGFB2;LRRFIP1;ADRB2;HNF4A;CADM1;SPPL2A;GBP4;HHEX;ACTN4;GCH1;EXT1;BLOC1S6;DEFA6;ACVR1;SLK;SSBP1;CAMK2D;TRIM6;KARS1;TPD52;IRAK2;GBP3;MYH9;WARS1;TOX3;EXD2;ZBTB16;LRRK2;TMEM192;ELAVL1;STAT1;HSPB1;MTPAP;CEBPA;PTPRO;HOOK1;BCL2L1;FLRT3;ZHX3;TENM3;ACOX1;TPD52L1;MIGA1;MMAA;NECTIN1;TCF3;ADAM10;MAP3K11;TYR;TAP1;TYROBP;CLCN1;CCDC88A;ABCG4;TENM4;NPM1;HIF1AN;GBP2;INPP5F;GSS;ACHE;RBM11;TRIM8;SOX6;FBXO4;HMGCS1;TPM4
prerank,1-phosphatidylinositol binding (GO:0005545),0.4899651687289456,1.1095307731952095,0.34923076923076923,0.7904188511479079,1.0,5/15,17.41%,EPB41;SNX10;ZFYVE9;ZFYVE16;SCARB1
prerank,exoribonuclease activity (GO:0004532),0.5116078261726226,1.1082631144230823,0.347008547008547,0.7898838908027788,1.0,6/12,22.43%,ZC3H12A;EXOSC3;EXOSC8;EXOSC9;EXOSC10;EXOSC1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.47008454446022585,-1.105575748161867,0.3333333333333333,0.7882967782167805,1.0,4/10,8.85%,SLCO2B1;SLCO3A1;SLC22A6;SLCO2A1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.44423265704998693,1.1047195400101708,0.33240611961057026,0.7957362185778372,1.0,12/27,24.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;MED21;POLR2C;POLR2B;POLR2J;PRIMPOL;POLR1C
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.38005373321187697,-1.1041195813980218,0.29428571428571426,0.7839376059460665,1.0,4/20,5.82%,SLC39A14;SLC30A10;SLC39A8;SLC39A13
prerank,GTPase binding (GO:0051020),0.3416309674044137,1.1020073060853568,0.2738990332975295,0.7994573680940982,1.0,43/195,15.77%,FGD5;UNC13B;RASIP1;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;FNBP1L;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;STK19;MYO1C;NCKAP1;RRAGD;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL;USP6NL;GNB2;RHOH;RAB11FIP4;BNIP3;LCP1;YBX1;PAK2;AP3M1;PEX5L
prerank,MHC protein binding (GO:0042287),0.4591536740204267,1.101265198768467,0.3451043338683788,0.7973228236103694,1.0,5/20,13.20%,TUBB;TUBB4B;ATP5F1A;TAP1;TAPBP
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.44605679441660634,1.1004496938232202,0.34750733137829914,0.795824522607577,1.0,2/29,5.33%,ACER2;HYAL2
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.5367508225250855,1.099269293815248,0.35365853658536583,0.795207395630084,1.0,4/10,15.26%,CASP8;CASP2;CASP1;CASP7
prerank,glycine binding (GO:0016594),0.5205409171929348,1.098346610793021,0.38220757825370677,0.7938270459769146,1.0,4/11,20.05%,GRIN2B;GRIN3A;GLRA2;GNMT
prerank,alpha-tubulin binding (GO:0043014),0.42845876534866895,1.0963042868115167,0.3631123919308357,0.795440211417318,1.0,3/31,3.59%,TRPV4;FYN;TTLL7
prerank,adenylyltransferase activity (GO:0070566),0.4573136763830836,1.096223634751133,0.3854660347551343,0.7917146432645058,1.0,6/21,8.16%,GPHN;KARS1;SELENOO;MTPAP;TENT4A;OAS2
prerank,receptor tyrosine kinase binding (GO:0030971),0.3910035748740333,1.095023149131156,0.34571062740076824,0.7911249655043809,1.0,15/56,17.43%,PITPNM3;PTPN14;CBL;ANGPT1;HYAL2;DUSP3;STAP1;PTPN1;TOB1;GRB14;RACK1;NCK1;ELMO2;SOCS5;PTPN2
prerank,acylglycerol O-acyltransferase activity (GO:0016411),-0.3823368333535995,-1.089049641977302,0.3263473053892216,0.82020245583855,1.0,5/20,9.80%,LPGAT1;MOGAT3;AGPAT4;LPCAT2;DGAT1
prerank,NAD binding (GO:0051287),-0.35794082011088396,-1.087926768185337,0.3241590214067278,0.8142090948763689,1.0,6/26,14.39%,ALDH1A1;ME1;SIRT3;BDH2;HPGD;SIRT2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4263105098657626,-1.0872800651769374,0.3785900783289817,0.8073852751948704,1.0,5/13,19.39%,SLC9A2;SLC9B2;SLC9A9;SLC9A1;SLC9A6
prerank,tumor necrosis factor receptor binding (GO:0005164),0.5123066281716986,1.0852640373149196,0.37796610169491524,0.8136155958960659,1.0,3/12,9.57%,TRAF1;STAT1;BABAM2
prerank,triglyceride lipase activity (GO:0004806),0.46141726802512706,1.0849169111949875,0.38738738738738737,0.8106257477402699,1.0,2/20,5.21%,PNLIP;LCAT
prerank,tau protein binding (GO:0048156),0.4015227405227352,1.0839378134018018,0.36662106703146374,0.8093905967749528,1.0,18/40,21.12%,FYN;TTBK2;SMAD2;PRKAA1;ROCK1;TAOK2;MARK3;ACTB;CLU;MARK2;TTBK1;PIN1;PPP2CB;MAP2;GSK3A;DYRK1A;GSK3B;MARK4
prerank,small GTPase binding (GO:0031267),0.33737064158815394,1.0823506067844453,0.3251072961373391,0.809960123091399,1.0,30/170,11.65%,FGD5;UNC13B;RABGAP1;ARHGEF2;CAV1;IQGAP1;TBC1D30;EHD1;SGSM1;RAPGEF4;RAB34;RAPGEF6;PKN1;FGD6;SIKE1;SH3BP4;WHAMM;RAB3GAP2;LRRK2;RANGAP1;STK19;MYO1C;NCKAP1;CYFIP1;STRN3;EXOC8;RANBP2;RANBP1;RANBP9;OCRL
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3226344727664399,1.0799598110146942,0.23323323323323322,0.8125378892098977,1.0,82/830,9.64%,PRDM16;MECOM;EPAS1;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;MSX1;DACH1;EBF1;KLF2;CASZ1;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;ACTN4;TEAD4;HEY2;KLF4;SIM2;LEF1;MAFK;IRF9;ZBTB46;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;PURA;EBF3;RBL1;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.41665659462166366,1.0786661599257572,0.3707865168539326,0.8121362216468692,1.0,2/32,6.04%,SLC6A6;SFXN1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.44190614469322187,-1.0778747466881344,0.36787564766839376,0.8263643598084521,1.0,3/12,2.89%,PDE7B;PDE3A;PDE8B
prerank,acetylation-dependent protein binding (GO:0140033),-0.376277293181683,-1.0769105491163145,0.35942028985507246,0.8116359968502346,1.0,8/20,19.98%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,lysine-acetylated histone binding (GO:0070577),-0.376277293181683,-1.0769105491163145,0.35942028985507246,0.8116359968502346,1.0,8/20,19.98%,PSME4;BRDT;TAF1;ZMYND8;BRD3;BRD9;BRD2;BRD7
prerank,lysine N-methyltransferase activity (GO:0016278),-0.37874125298267175,-1.0760883932590153,0.36555891238670696,0.8057473481525466,1.0,13/20,35.02%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SETD4;EEF1AKMT2;ANTKMT;KMT5A;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,metal ion transmembrane transporter activity (GO:0046873),0.4204572332174523,1.0753706396731528,0.3588652482269504,0.8173603578276246,1.0,2/27,1.78%,ATP2A3;ATP2B4
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),-0.32830495393633724,-1.075137657885627,0.3163265306122449,0.8004218825557148,1.0,9/38,12.28%,SERPING1;TFPI;ANXA2;SERPINE2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.40589514837843044,1.074614105276897,0.361794500723589,0.8155731797984388,1.0,11/34,22.04%,REXO2;EXD2;EXOSC3;CNOT6L;CNOT1;XRN2;ANGEL2;CNOT2;EXOSC9;EXOSC10;DIS3L2
prerank,phosphatase binding (GO:0019902),0.3540137655939813,1.073998039125424,0.3683602771362587,0.8134259881985751,1.0,12/105,7.44%,KCNN4;CEACAM1;FLT4;ITGA1;FBXL2;IQGAP1;SH3YL1;CHCHD3;SMAD2;MAPK1;SHOC2;HSP90B1
prerank,microtubule minus-end binding (GO:0051011),0.4915468300403944,1.0731467029348645,0.37891268533772654,0.8120489315352777,1.0,3/13,11.08%,MACF1;CAMSAP2;NUMA1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3212577194947948,1.0731327562386246,0.2602602602602603,0.8083311398064106,1.0,76/730,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;TRIM24;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,symporter activity (GO:0015293),-0.46406377502981605,-1.0729978528850246,0.3768472906403941,0.7987944490206208,1.0,10/10,53.63%,SLC5A5;MFSD2A;SLC4A4;SLC46A2;SLC28A2;SLC5A6;SLC28A3;SLC5A8;SLC28A1;SLC5A12
prerank,phosphatidylcholine transporter activity (GO:0008525),0.46691631253406274,1.071351635854032,0.37846153846153846,0.8094463506750141,1.0,6/17,15.39%,ATP10A;PLTP;ABCB4;PITPNA;ATP8B1;ABCA7
prerank,hydro-lyase activity (GO:0016836),-0.3146490283619021,-1.0703032331194164,0.3235294117647059,0.7989720398317632,1.0,16/41,29.82%,GMDS;HACD1;CA2;ACO1;ENO2;ECHDC3;EHHADH;ECHDC2;ENO3;ACO2;FAHD2A;ALAD;ECHS1;CA4;HACD3;L3HYPDH
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3204123530491061,1.069720007747395,0.25851703406813625,0.8100596544702651,1.0,75/731,9.99%,PRDM16;MECOM;SOX17;SOX13;KLF8;ERG;IRF6;GATA6;GATA2;TAL2;DACH1;EBF1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;TAL1;OLIG2;KLF7;IRF2;ZNF296;ZNF235;LRRFIP1;HNF1A;HNF4A;KLF3;KLF6;SOX18;HHEX;TEAD4;HEY2;KLF4;LEF1;MAFK;IRF9;SP4;MAFF;FOXF2;MEF2C;SMAD2;ZBTB48;FOSL2;GATA3;BCL6B;RXRG;ZBTB16;GTF2IRD1;STAT1;EBF3;CEBPA;NLRC5;NFE2L2;NR1D1;SNAI2;KLF11;ZBTB40;FOXP1;JUN;TCF7L1;TCF3;EGR1;ZNF182;DHX9;PLAG1;ZBTB14
prerank,rRNA binding (GO:0019843),0.4029836901015888,1.069380132058052,0.3659863945578231,0.8073045727466445,1.0,22/42,29.74%,TST;MRPL18;NGRN;RPS14;DDX28;RPS9;CAVIN1;RPS5;DDX21;FASTKD5;ANG;MRPL11;NOP53;MRPS27;RPF2;MRPS18C;ERI1;RPS13;RPL11;ERAL1;MRPS18A;FASTKD2
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.35847922648699493,-1.069061639927626,0.35435435435435436,0.7947422061513117,1.0,4/26,4.38%,PTN;PPP1R1A;SET;BOD1L1
prerank,Tat protein binding (GO:0030957),0.5184072544267733,1.0686879433169214,0.384070796460177,0.8053835702656776,1.0,5/10,23.33%,GABARAPL1;ACTB;NPM1;DNAJA1;DLL1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.441991202342399,-1.0674993226238305,0.3832923832923833,0.7915399370064523,1.0,5/12,7.80%,IGF1;SHC1;IRS1;PIK3R1;IGF2
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.3916073984024387,1.065432122159443,0.38823529411764707,0.8104602764511316,1.0,6/46,4.59%,GCNT1;MFNG;POMGNT1;EXT1;MGAT5;GCNT2
prerank,single-stranded RNA binding (GO:0003727),0.3933687920855792,1.06316002618093,0.3948439620081411,0.8128205220074122,1.0,9/43,13.08%,IFIH1;RBM7;ENDOV;POLR2G;DHX9;POLR2D;AGO4;RBM11;FXR1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.40513172179462886,-1.062358249769235,0.39095744680851063,0.7982257979640253,1.0,8/15,25.04%,KMT2C;ASH2L;SETD1A;SETD1B;WDR5;SETD4;KMT2D;SETMAR
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4219846406863888,1.0613904168396093,0.3748125937031484,0.8139030046788401,1.0,8/28,18.54%,DAB2IP;TRAF1;MADD;STAT1;BABAM2;CASP8AP2;SIVA1;BID
prerank,sterol binding (GO:0032934),-0.29578775695348825,-1.0605135982856806,0.37438423645320196,0.7955699067989126,1.0,18/56,17.11%,APOD;SIDT1;ABCA1;GRAMD1C;RORA;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;INSIG2;CD81;GRAMD1A;OSBPL7;OSBPL11;NR1H3;SCAP;GRAMD1B
prerank,miRNA binding (GO:0035198),0.41178821466269355,1.057153395399917,0.37375178316690444,0.8214363863908348,1.0,9/30,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;AGO4;DDX21;YBX1;TUT7
prerank,iron ion binding (GO:0005506),-0.2969894513697981,-1.0507929021787543,0.3644067796610169,0.8155358564850242,1.0,13/48,14.63%,AGMO;KDM7A;NFU1;EGLN3;FTO;TET2;JMJD6;AOX1;FDX1;TET1;ETHE1;FXN;SCD
prerank,mannosyltransferase activity (GO:0000030),-0.36834492871216523,-1.0494418137011308,0.39669421487603307,0.8117794561101782,1.0,7/21,20.24%,TMTC4;TMTC1;PIGB;POMT1;ALG8;ALG9;PIGZ
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.3626225992299063,-1.048483297672929,0.3950617283950617,0.806997051080986,1.0,3/24,5.83%,DAPK1;CAMK1D;CAMK1
prerank,endopeptidase activity (GO:0004175),-0.2302639847374925,-1.0469748148150595,0.21739130434782608,0.8038009858155328,1.0,59/257,19.11%,TRABD2B;ADAMTS2;ADAMTS12;ADAMTSL3;THSD4;ADAMTSL5;BACE2;MMP14;HTRA3;ADAMTS17;RHBDL3;ADAMTS5;ADAMTS10;DPP4;USP33;USP20;BACE1;ADAMTS3;FAP;ADAM19;USP9X;ADAM9;USP13;USP11;ADAMTS15;ADAMTS9;F3;MMP2;ADAM33;USP1;CASP3;PSMB3;ADAMTSL4;MMP16;KLK2;ZMPSTE24;MMP19;UCHL1;SENP1;ADAMTS14;PCSK7;PSMA3;PSMB4;USP8;CTSC;ADAMTS16;MMP11;PSMB7;USP34;MBTPS1;CTSL;CASP4;MASP1;RHBDF1;HTRA4;ACE2;HTRA2;ADAMTS19;KDM8
prerank,outward rectifier potassium channel activity (GO:0015271),0.48962166448688266,1.0444789815851088,0.4523809523809524,0.8516671102332459,1.0,1/11,0.28%,KCNQ1
prerank,death domain binding (GO:0070513),0.48891635415618323,1.0427502049219903,0.43265993265993263,0.8524624586150382,1.0,6/11,19.51%,DAP;CRADD;IRGM;BCL2L1;RACK1;MCL1
prerank,adenyl ribonucleotide binding (GO:0032559),0.31870164275563195,1.0417085921421236,0.38605619146722164,0.8515098116227247,1.0,51/291,12.82%,RAPGEF2;MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;RAPGEF4;MAP4K4;STK38;STK38L;NLK;GLUD1;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;ACSS2;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.4111909094643459,-1.0402259052916893,0.3925925925925926,0.8148082807778175,1.0,9/14,28.03%,ALDH4A1;MTHFD1;BLVRB;MTHFR;PYCR2;ALDH1L1;ALDH1L2;DHFR;PYCR3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3692133362267679,1.0389269918290125,0.41102756892230574,0.8551445413366238,1.0,9/60,7.26%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;FGFR3;ALK;LMTK2
prerank,C-C chemokine binding (GO:0019957),0.4290750368145677,1.0384814236058446,0.41836734693877553,0.8525872917735479,1.0,3/22,14.74%,CCR1;CX3CR1;CXCR4
prerank,metalloexopeptidase activity (GO:0008235),-0.3014636346794619,-1.0383584677092934,0.37662337662337664,0.8126559552697741,1.0,14/51,13.35%,AEBP1;CPQ;MMP14;ANPEP;CPE;AGBL3;METAP1D;CPXM2;MMP16;CPXM1;ZMPSTE24;ENPEP;METAP1;RNPEP
prerank,RNA polymerase II complex binding (GO:0000993),-0.3319467922594491,-1.038259085219872,0.39100346020761245,0.8057273145202627,1.0,12/32,16.42%,SCAF8;PAF1;ERCC5;PCIF1;CTR9;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.39364157232174507,1.0379939742902222,0.40441176470588236,0.850090842303552,1.0,7/33,12.67%,REXO2;EXD2;EXOSC3;CNOT6L;XRN2;ANGEL2;XRN1
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.41537964907041663,-1.037346184162312,0.38461538461538464,0.8012378779891055,1.0,3/12,5.36%,BACE2;BACE1;HM13
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4204517939314073,1.0353236216145738,0.41841004184100417,0.853467305442547,1.0,12/27,24.82%,POLR2G;POLR3B;POLR1F;POLR2D;POLR1D;POLR2I;TENT2;MED21;POLR2C;POLR2B;POLR2J;POLR1C
prerank,kinase activity (GO:0016301),0.3431183603112379,1.035295412531497,0.4290697674418605,0.8498192487783325,1.0,28/109,17.90%,ITPKB;IP6K3;PRKD1;PIK3C2A;IPPK;IDNK;PGM2L1;MAP4K4;PGK1;LRRK2;RFK;STK39;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;CKMT1A;TRRAP;PKN2;GK5;DOLK;TRIB3;CERKL;PIK3C2B
prerank,DNA binding (GO:0003677),0.3099345216832736,1.033491315891102,0.3937875751503006,0.8508854385939881,1.0,99/694,13.78%,PRDM16;MECOM;EPAS1;SOX13;ERG;IRF6;TAL2;KLF2;SMARCA2;TBX1;NR4A2;FOXO4;FOXO1;KLF12;AIM2;IRF2;LRRFIP1;HNF1A;HNF4A;ARID3B;APP;HHEX;FLI1;RBBP8;HEY2;HMBOX1;ING2;SIM2;LEF1;BCLAF3;SYCP2;MAFK;SSBP1;SP4;MAFF;FOXF2;SMAD2;RPL7;APEX1;GATA3;RTF1;CHCHD2;CHRAC1;SETX;ENDOV;RYBP;ZBTB16;ZC3H12A;STAT1;PURA;CEBPA;NFE2L2;POLR2G;TIGD3;SNAI2;FEN1;ERF;POGK;MBD1;JUN;TCF7L1;TCF3;STN1;EGR1;HMGB1;MLF1;DHX9;TIGD2;HP1BP3;ARID5A;ZBTB14;POLR2D;BRIP1;APLP2;NUP35;POLA1;POLG2;PCBP1;BRCA1;NR4A1;SMARCAD1;SAP30L;ILF2;MTERF2;ARID5B;SOX10;HINFP;SOX6;IRF5;XRN1;CBFB;GLYR1;POU3F2;GTF2A1;CR2;HIF1A;RAD1;ERCC4;RAD51D
prerank,phosphate ion binding (GO:0042301),0.499765174403661,1.0327173543454042,0.43992932862190814,0.849216267361731,1.0,5/10,25.16%,CHST14;RELA;ADSS2;MTHFD2;RPH3A
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3921705488073977,-1.0315789575229537,0.42317380352644834,0.8099158432611048,1.0,2/14,2.86%,SLC26A7;SLC26A2
prerank,"DNA binding, bending (GO:0008301)",0.4589735343399081,1.0309719743752392,0.44749596122778673,0.850363757548726,1.0,5/14,14.54%,HHEX;LEF1;HMGB1;SAP30L;HMGB2
prerank,ATP binding (GO:0005524),0.31763253288337157,1.030606029633842,0.4183350895679663,0.847819727528336,1.0,47/266,12.82%,MAP4K2;RPS6KA5;ACVRL1;MAP4K3;INSR;ATP1A1;ATP1A3;SNRK;OXSR1;CDC42BPA;SYN3;MAP3K6;CDC42BPG;ACVR1;ATP7A;MAP4K4;STK38;STK38L;NLK;MYH9;PGK1;PXK;UHMK1;MAST1;P2RX7;AKT3;SIK2;LMTK2;HSPA1B;ATP5F1A;MTPAP;NVL;TLK1;OAS2;ABCF2;CAD;EIF2B2;MLKL;DHX9;TAP1;MINK1;ABCC6;NEK11;GSS;MARK2;BTK;VPS4A
prerank,calcium-release channel activity (GO:0015278),0.44702151410247504,1.030385716188825,0.4367816091954023,0.8448078836294345,1.0,4/17,11.28%,ITPR3;MCOLN1;TPCN2;TRPM2
prerank,tau-protein kinase activity (GO:0050321),0.4370468082758762,1.029913977088658,0.42113564668769715,0.8423748404635537,1.0,12/20,21.12%,FYN;TTBK2;PRKAA1;ROCK1;TAOK2;MARK3;MARK2;TTBK1;GSK3A;DYRK1A;GSK3B;MARK4
prerank,chloride channel regulator activity (GO:0017081),0.463980338341306,1.029424888904082,0.43729903536977494,0.8400938392617437,1.0,4/14,9.30%,VTI1B;STX7;VAMP8;SGK1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4624084015103034,1.0283844185377036,0.44038155802861684,0.8391546675758541,1.0,3/15,7.29%,PIK3R6;CISH;SOCS6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.4000724057404239,-1.0267467029195863,0.41643835616438357,0.8158388171572416,1.0,4/14,10.73%,USP9X;USP13;MINDY3;OTUD7B
prerank,transition metal ion binding (GO:0046914),0.31293362725425294,1.025009461093607,0.4298780487804878,0.8444138965258685,1.0,60/397,12.28%,NOS1;MYRIP;NOS3;ACE;CRIP2;GDA;ARHGEF2;POMGNT1;DUSP12;MSRB3;KLF7;IFIH1;ATOX1;GCH1;MGAT5;KLF4;FBXL5;ATP7A;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ARG1;ASAH2;ARIH1;IL1A;PCK2;PGGT1B;TRIM24;CLIP1;EXD2;KDM3A;KPNB1;MT2A;MTPAP;PLSCR1;GRIN2B;CAD;FEN1;MBD1;KMT2B;DHH;EGR1;TYR;ADPRM;PRNP;PTPN1;TET3;TAB2;TNKS;MGAT1;ALKBH8;HIF1AN;XXYLT1;ISCA2;SAP30L;GALNT4;TRIM8;SUV39H2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.3801245746620291,-1.0190190694939336,0.45403899721448465,0.8301447200367036,1.0,6/16,22.92%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;CFTR;CLCN6
prerank,titin binding (GO:0031432),0.47795455612891724,1.0188229328571727,0.4612736660929432,0.8567081354595972,1.0,3/13,12.45%,MYBPC3;CAMK2D;CALM3
prerank,syntaxin binding (GO:0019905),0.35393134990378844,1.0184828651191578,0.43638676844783714,0.8540375670718755,1.0,19/61,18.29%,UNC13B;RAB11A;CACNA1A;BLOC1S6;STX7;TMED10;LRRK2;VAMP8;TMED9;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5L;STXBP5;PTPN2;SYT1;SYT2
prerank,cyclic nucleotide binding (GO:0030551),0.41742496590194245,1.0159562785218805,0.4457831325301205,0.857108405058019,1.0,5/21,17.25%,RAPGEF2;RAPGEF4;POPDC3;PDE4D;KCNH1
prerank,double-stranded DNA binding (GO:0003690),0.3042954991202892,1.015177598375398,0.4586693548387097,0.8555451369971944,1.0,70/531,13.59%,ERG;IRF6;GATA6;GATA2;MSX1;KLF2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;FOXQ1;EGR3;ELK3;NR1I3;KLF12;HEY1;AIM2;OLIG2;IRF2;ZNF296;HNF4A;KLF3;KLF6;SOX18;FLI1;RBBP8;HEY2;HMBOX1;KLF4;LEF1;IRF9;MAFF;MEF2C;SMAD2;ZBTB48;APEX1;GATA3;BCL6B;RXRG;STAT1;PURA;NR1D1;SNAI2;FEN1;KLF11;FOXP1;MBD1;JUN;TCF7L1;EGR1;HMGB1;DHX9;ZBTB14;POLG2;PHOX2A;E2F7;NR4A1;KLF13;SOX10;TLX3;IRF5;ELF2;TGIF1;POU3F2;ZNF32;UNCX;TBX20;NFATC1
prerank,nuclear export signal receptor activity (GO:0005049),0.4706383805577108,1.0147063024572758,0.42807625649913345,0.8531916583536332,1.0,4/11,14.41%,XPO6;XPO1;RAN;NUP42
prerank,histone demethylase activity (GO:0032452),-0.3394086015589981,-1.0132662065907536,0.41724137931034483,0.8390780156315499,1.0,10/27,20.13%,KDM7A;JARID2;JMJD1C;JMJD6;FBXL19;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.3783202817482856,1.011513212524659,0.4567243675099867,0.8577801576797165,1.0,14/40,22.51%,PCMTD1;COMTD1;PCMT1;METTL2A;METTL2B;SETD3;FBLL1;GAMT;METTL18;ARMT1;METTL4;GNMT;LCMT1;FBL
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),-0.31873170515674687,-1.0087663696256106,0.39322033898305087,0.8440708491471708,1.0,13/33,17.11%,SCAF8;PAF1;ERCC5;CTR9;LLPH;URI1;UVSSA;RTRAF;GTF2B;HNRNPU;PCF11;WAC;AR
prerank,ATPase regulator activity (GO:0060590),-0.3020448179812253,-1.0081926342260759,0.4362934362934363,0.8387464329973686,1.0,16/38,23.63%,ATP1B3;TOR1AIP1;SIL1;ATP5IF1;FNIP1;DNAJB2;BAG1;BAG3;ATP1B1;TSC1;ATP1B2;GRPEL2;KATNB1;DNAJB4;DNAJC15;BAG2
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.3475077461225272,-1.0078132299563676,0.43597560975609756,0.8328388736091139,1.0,3/21,5.87%,FGF1;FGF2;KL
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.3776581642443412,1.0069750662092145,0.4488078541374474,0.8656322973997425,1.0,7/37,10.20%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.41349156512777885,1.005859287173558,0.47058823529411764,0.8649399557131591,1.0,3/24,7.42%,ITPKB;IP6K3;CMPK1
prerank,frizzled binding (GO:0005109),-0.31367554507121725,-1.0050270376693635,0.45307443365695793,0.833250931391932,1.0,7/34,10.19%,WNT4;RNF43;WNT6;WNT5A;WNT9A;FZD7;SDCBP
prerank,phosphatidylglycerol binding (GO:1901611),0.4680003646990635,1.0041396449129687,0.45517241379310347,0.8658018749337167,1.0,3/13,8.63%,PLTP;UQCC3;PITPNA
prerank,adrenergic receptor binding (GO:0031690),0.440275647385865,1.004022237704055,0.4767255216693419,0.8625931416305589,1.0,2/16,5.18%,RAPGEF2;AKAP5
prerank,TBP-class protein binding (GO:0017025),0.41974804269258087,1.0031108706574037,0.4514705882352941,0.8614298599845335,1.0,9/21,17.58%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1
prerank,kinesin binding (GO:0019894),0.4041822158141739,1.0026090923043842,0.45845697329376855,0.8591688945844104,1.0,8/27,16.27%,TTBK2;SPAG9;NEFH;ACTB;KLC2;PRC1;ARHGEF10;PLEKHM2
prerank,voltage-gated potassium channel activity (GO:0005249),0.3437889519497001,1.002305758458177,0.456441717791411,0.8565002602938132,1.0,5/80,3.68%,KCNQ1;KCNE3;KCNH8;KCNN3;KCNG3
prerank,mechanosensitive ion channel activity (GO:0008381),0.4688243409402997,1.0019901938972675,0.45977011494252873,0.8538526388716458,1.0,2/12,7.94%,PIEZO1;TMC7
prerank,5'-3' exonuclease activity (GO:0008409),0.4644057126835515,1.0019498867401289,0.46895424836601307,0.8505847998372792,1.0,7/14,20.19%,TRIR;FEN1;XRN2;XRN1;EXOG;DXO;CPSF3
prerank,pentosyltransferase activity (GO:0016763),-0.2991198344122464,-1.0008529587919346,0.45038167938931295,0.8372867224031967,1.0,13/36,24.62%,LARGE1;PARP8;LACC1;SIRT3;ART3;PNP;SIRT2;QPRT;PARP3;PARP1;PARP6;PPAT;PARP2
prerank,water transmembrane transporter activity (GO:0005372),0.47157306547431704,1.000671431673631,0.4787052810902896,0.8504546001104766,1.0,1/11,2.23%,AQP11
prerank,phospholipase binding (GO:0043274),-0.3967279254654405,-0.9994689920486323,0.4595959595959596,0.8343869510986286,1.0,3/13,6.78%,ARHGAP6;PRKN;SRC
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.4463423381200688,0.9941861213152622,0.4806451612903226,0.8630224649638198,1.0,7/16,26.64%,MTMR10;MTMR11;INPP5F;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,cytokine activity (GO:0005125),-0.2467553077865528,-0.9939977030585511,0.5535714285714286,0.841852864999097,1.0,14/131,9.65%,BMP6;IL34;WNT4;BMP5;BMP7;BMP4;WNT6;WNT5A;TNFRSF11B;FGF2;CXCL16;WNT9A;VEGFA;IL17D
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4381249789055469,0.9936604115485462,0.48753894080996885,0.860921715047103,1.0,7/15,22.75%,PIK3C2A;PIK3C3;PIK3CB;ATM;PIK3C2B;PIK3R3;PIK3CA
prerank,potassium:proton antiporter activity (GO:0015386),-0.42108581705750564,-0.9925357407551474,0.47880299251870323,0.8385943847990283,1.0,4/10,19.39%,SLC9A2;SLC9A9;SLC9A1;SLC9A6
prerank,chloride channel inhibitor activity (GO:0019869),0.4798259379027262,0.9916021990105984,0.48148148148148145,0.8623780591628966,1.0,3/10,7.40%,VTI1B;STX7;VAMP8
prerank,omega peptidase activity (GO:0008242),-0.25616190012192747,-0.9910574024562356,0.48466257668711654,0.8358363798700542,1.0,28/89,21.74%,USP33;USP20;ASRGL1;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;GGT5;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;GGT7;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,active ion transmembrane transporter activity (GO:0022853),-0.29808510350199235,-0.9880801923726427,0.4139194139194139,0.836798994440688,1.0,9/37,12.96%,SLC22A8;SLCO2B1;SLCO3A1;SLC22A6;SLC22A4;SLCO2A1;COX10;COX7A2L;UQCRQ
prerank,GABA receptor activity (GO:0016917),0.4084249535765267,0.9862379065324314,0.4919236417033774,0.8722743037576095,1.0,7/21,21.41%,GABRQ;GABRA4;GABRA2;GABRE;GABRG3;GABRB1;GABRB3
prerank,ion channel activity (GO:0005216),0.33546779344283595,0.9862320700400512,0.4742014742014742,0.8689510065575786,1.0,13/80,11.28%,TRPV4;PIEZO1;MCUB;GRID1;GRIA1;MCOLN1;TMC7;GRIN2B;GRIN2C;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,regulatory RNA binding (GO:0061980),0.3711302820302257,0.9852387705500244,0.46511627906976744,0.8681597161169006,1.0,10/38,17.51%,PUM2;ZC3H12A;ELAVL1;ZNF346;ZC3H7A;DHX9;AGO4;DDX21;YBX1;TUT7
prerank,kinase activator activity (GO:0019209),-0.317352073935786,-0.9843360856322285,0.4984520123839009,0.8401843273137225,1.0,3/30,5.62%,PRKAG2;WNK1;GPRC5C
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4520653675820459,0.9831657677535701,0.48292682926829267,0.869730134325862,1.0,6/14,26.64%,MTMR10;MTMR11;SYNJ1;MTMR14;MTMR2;MTMR9
prerank,protein heterodimerization activity (GO:0046982),0.30711291077188135,0.9831347256961085,0.5123789020452099,0.8665654601119265,1.0,36/178,16.40%,EPAS1;HIP1;PDGFB;NR4A2;ATP1A1;RALGAPA1;FBXO7;EXT1;MEF2C;IRAK2;BCL2L1;ZHX3;TENM3;MIGA1;TCF3;RRAGD;ABCG4;TENM4;CYBA;RALGAPB;NR4A1;TPM4;YWHAH;FXR1;GTF2A1;SDCBP2;HIF1A;RALGAPA2;USF2;RAN;ITGA3;FZD9;VAPA;TCOF1;TENM2;TENM1
prerank,retinoic acid receptor binding (GO:0042974),0.4231914434094443,0.9823870348565121,0.48032786885245904,0.86510146682451,1.0,4/17,10.22%,NR4A2;ACTN4;ARID5A;CNOT1
prerank,syntaxin-1 binding (GO:0017075),0.4092035132900868,0.9808118005588606,0.5055292259083728,0.8654624743384508,1.0,9/22,18.19%,UNC13B;LRRK2;SYPL1;STXBP3;NSF;CPLX1;SNPH;STXBP5;SYT1
prerank,androgen receptor binding (GO:0050681),-0.33205089838006147,-0.980721378016844,0.49673202614379086,0.8434603555045015,1.0,4/25,5.23%,DDX5;PRKCB;SNW1;NSD1
prerank,phospholipase activator activity (GO:0016004),-0.4267853496728639,-0.9784507401784625,0.47073170731707314,0.8429808913914071,1.0,3/10,6.78%,ARHGAP6;STX4;SRC
prerank,RNA polymerase binding (GO:0070063),0.42532524598686217,0.9784454454142565,0.4720496894409938,0.8677086228395691,1.0,6/18,15.68%,STOM;TCERG1L;DHX9;BRCA1;ANP32B;PKN2
prerank,translation initiation factor activity (GO:0003743),0.37700602140261835,0.9782733530546762,0.5063291139240507,0.8648105438835325,1.0,13/36,17.85%,EIF3B;EIF2B2;EIF1;EIF3K;EIF3I;EIF3F;EIF3G;EIF3A;EIF2S1;EIF2A;EIF3H;COPS5;EIF3M
prerank,metalloaminopeptidase activity (GO:0070006),-0.37109341210456553,-0.976830603517935,0.4715909090909091,0.8408941487265933,1.0,5/16,13.35%,MMP14;ANPEP;MMP16;ENPEP;RNPEP
prerank,DNA secondary structure binding (GO:0000217),0.380909462258483,0.9739956139593938,0.5028735632183908,0.8713867423619244,1.0,11/31,24.06%,RBBP8;MEF2C;HMGB1;RAD51D;RAD18;HMGB2;XPC;MEN1;BLM;GEN1;WRN
prerank,transcription coactivator binding (GO:0001223),-0.34919811981502963,-0.9727602206820091,0.49854227405247814,0.8450422453696359,1.0,5/20,17.11%,RORA;THRB;SMAD3;TERT;AR
prerank,3'-5' exonuclease activity (GO:0008408),0.35015651355257815,0.9724033957451138,0.48137931034482756,0.8718786223145427,1.0,11/45,17.49%,REXO2;APEX1;EXD2;TRIR;EXOSC3;CNOT6L;XRN2;ANGEL2;RAD1;EXD1;EXOSC9
prerank,peptidase activator activity (GO:0016504),0.3979168792612857,0.9692671958146355,0.503030303030303,0.8762601901231721,1.0,6/22,11.78%,CAV1;MAL;APH1A;VSIR;PSMD14;CASP8AP2
prerank,acid-thiol ligase activity (GO:0016878),0.44753970715185765,0.9664186818290604,0.5033783783783784,0.8800194137081152,1.0,4/13,14.79%,ACSM3;ACSS2;AACS;SLC27A2
prerank,snRNA binding (GO:0017069),-0.28885001643764374,-0.9659143250263479,0.48221343873517786,0.8564890943485313,1.0,15/42,25.88%,SNRNP70;PRPF8;COIL;GEMIN5;PRPF31;SNRPA1;TUT1;SNRPA;HNRNPU;SNRPD3;LSM11;TOE1;NCBP2;LSM10;LARP7
prerank,tropomyosin binding (GO:0005523),0.42218997976645395,0.9618128834090048,0.5109717868338558,0.8876266481445019,1.0,1/16,0.60%,NEBL
prerank,peptidase inhibitor activity (GO:0030414),-0.30084927622112584,-0.9617239643348182,0.5469255663430421,0.8612246820124739,1.0,7/33,11.60%,TFPI;GPC3;TIMP2;PSMF1;RENBP;SERPIND1;ITIH2
prerank,ribosomal large subunit binding (GO:0043023),-0.4078913884713889,-0.961346950357753,0.4878640776699029,0.8559854058758104,1.0,5/11,18.55%,NEMF;MRRF;CPEB2;NMD3;MALSU1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4408856036156879,0.9610867240321118,0.5050675675675675,0.8861838855442858,1.0,9/13,31.65%,TRMT5;TRMT10B;TRMT1L;TRMT1;THUMPD2;TRMT10A;TRMT10C;FTSJ1;TRMT11
prerank,leucine zipper domain binding (GO:0043522),-0.41119881122241275,-0.9595514726443468,0.5091383812010444,0.8544033058516384,1.0,1/10,0.42%,PAWR
prerank,methylated histone binding (GO:0035064),-0.2589419293460625,-0.9592113213826522,0.5147058823529411,0.8488852274949533,1.0,20/62,20.26%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;TAF1;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;TAF7;MORC3;KDM8;PHF8;ATRX
prerank,cholesterol binding (GO:0015485),-0.2739951375861516,-0.9591706618281635,0.4793388429752066,0.842885637611758,1.0,14/47,17.11%,APOD;SIDT1;ABCA1;GRAMD1C;OSBPL8;SCP2;PTCH1;OSBP2;ERLIN1;CD81;GRAMD1A;OSBPL7;NR1H3;GRAMD1B
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41308445126670856,-0.9569625825158662,0.5128205128205128,0.8421550974558144,1.0,3/10,12.40%,CACNA1C;CACNB1;CACNB2
prerank,solute:proton symporter activity (GO:0015295),-0.35867672564646325,-0.9567895929245729,0.5235602094240838,0.8364987065930843,1.0,4/16,11.74%,SLC2A13;SLC17A5;SLC39A8;SLC2A10
prerank,nucleosomal DNA binding (GO:0031492),-0.3324567889842608,-0.9544419709545597,0.5299145299145299,0.8364327727360625,1.0,8/21,22.68%,CHD4;SMARCB1;HDAC1;HMGA2;MTA2;MBD3;H1-0;ACTL6A
prerank,methylation-dependent protein binding (GO:0140034),-0.26113485130888436,-0.9519460747742926,0.5636363636363636,0.8367217138395173,1.0,18/57,20.26%,TDRD3;KDM7A;PYGO1;MTF2;MORC4;ZMYND8;WDR5;NCAPG2;RRP8;MSH6;BPTF;MPHOSPH8;MSL3;KDM4A;MORC3;KDM8;PHF8;ATRX
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.37906824314438725,0.9505564436185112,0.5423476968796433,0.9078536019165567,1.0,12/28,24.98%,APEX1;ENDOV;FEN1;RPP38;EDC3;ELAC2;DROSHA;POP1;NUDT16;RNASEH2A;RNASEH1;NUDT16L1
prerank,fatty acid synthase activity (GO:0004312),0.467080771339945,0.9494107961977647,0.5199335548172758,0.90741186339026,1.0,4/10,21.91%,ELOVL4;ELOVL7;ELOVL5;OXSM
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2876586973997814,0.9489516043462408,0.6199186991869918,0.9051253553447182,1.0,75/346,19.79%,LMO7;ASB4;TRIM14;RNF103;ZNRF1;TRIM69;CBL;HERC2;FBXO7;UBA7;FBXL14;FBXL5;TRIM11;TRIM6;RNF38;TRAF1;RNF125;RNF185;ARIH1;CUL3;UBE2Q1;UBE2D1;TRIM24;KLHL20;WWP1;UBE3A;RNF128;RNF141;RNF115;RBX1;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;RNF144B;TRIM17;FBXW2;NEDD4L;OBI1;BRCA1;DTX3L;RSPRY1;FBXO4;SMURF1;KCTD10;UBE2T;RMND5B;UBE2J2;RNF103-CHMP3;FBXO3;FBXO2;UBE2E1;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;TRAIP;RNF139;KLHL9;SEL1L;RNF150;FBXO6;FBXO10;MKRN1;XIAP;FBXL6;MALT1;ANAPC4;RNF166;MKRN2;BARD1;MAEA;RNF5
prerank,exonuclease activity (GO:0004527),0.3460854341768155,0.9475764519431968,0.5132978723404256,0.9051085272935439,1.0,14/46,17.70%,REXO2;APEX1;EXD2;ZC3H12A;TRIR;EXOSC3;FEN1;XRN2;EXOSC8;RAD1;EXOG;EXD1;EXOSC9;DXO
prerank,MHC class II protein complex binding (GO:0023026),-0.4060733156739297,-0.9465505299988276,0.5066371681415929,0.8442483842821705,1.0,3/11,17.88%,CD81;ATP1B1;CD74
prerank,ligand-gated cation channel activity (GO:0099094),0.32745195790336085,0.9462506795953239,0.5540201005025126,0.9048953688808905,1.0,11/75,11.28%,KCNN3;P2RX7;GRIA1;MCOLN1;GRIN2B;GRIN2C;ASIC2;GRIK5;GRIK2;GRIN3A;TRPM2
prerank,transcription corepressor binding (GO:0001222),-0.31591828449979453,-0.945943362051887,0.5412844036697247,0.8398180271871407,1.0,8/27,15.92%,MTF2;RORA;LCOR;USP11;EHMT1;HDAC6;NEK6;PER3
prerank,gated channel activity (GO:0022836),0.42746435648818315,0.9440775068489449,0.5387045813586098,0.906753083637854,1.0,2/14,7.94%,PIEZO1;TMC7
prerank,nucleotide diphosphatase activity (GO:0004551),-0.37489900562924744,-0.9430250988093001,0.5420054200542005,0.8409658657903516,1.0,3/14,4.91%,NUDT4;FHIT;ENPP1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.42023343075713304,0.9429672565876563,0.5380875202593193,0.905845939005694,1.0,4/15,14.60%,HS3ST1;HS3ST6;HS3ST5;NDST4
prerank,myosin II binding (GO:0045159),0.462486954864991,0.9415657822657645,0.5383333333333333,0.90594827006938,1.0,4/10,16.81%,SHROOM4;SHROOM1;STXBP5L;STXBP5
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.3450466376633284,-0.939138648479104,0.5306122448979592,0.8447730833880467,1.0,2/18,0.60%,ALDH1A1;ALDH1A2
prerank,aminopeptidase activity (GO:0004177),-0.3060133034225002,-0.9382308301431703,0.5275080906148867,0.8410920178031145,1.0,7/26,13.35%,MMP14;ANPEP;METAP1D;MMP16;ENPEP;METAP1;RNPEP
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4038308546929383,0.9339542342914867,0.5403726708074534,0.9195033248695577,1.0,3/18,7.29%,PIK3R6;CISH;SOCS6
prerank,signal sequence binding (GO:0005048),0.34854331272284533,0.9330075712380325,0.5296735905044511,0.918529850908086,1.0,13/35,21.92%,AP2B1;TOMM20L;KPNB1;BABAM2;AP2M1;NFKBIA;NUP153;KPNA3;CABP1;PEX5L;IPO4;KCNIP2;BRAP
prerank,endopeptidase inhibitor activity (GO:0004866),0.3176054842607517,0.9317272415833343,0.5775335775335775,0.9183187322732931,1.0,13/82,11.08%,RECK;SERPINI1;APP;SPOCK2;TIMP3;SPOCK3;FURIN;PTTG1;GAPDH;ROCK1;PRNP;SPINT2;SPOCK1
prerank,voltage-gated ion channel activity (GO:0005244),0.42894297415705773,0.9279437415261433,0.5489566613162119,0.9233724212773569,1.0,6/14,24.23%,ANO6;VDAC1;CACNA1E;VDAC3;HCN1;VDAC2
prerank,ubiquitin-dependent protein binding (GO:0140036),0.4594027846378854,0.9266188890274267,0.5591766723842195,0.9229583360462406,1.0,3/10,11.23%,ANKRD13A;DNAJC2;LAPTM5
prerank,GTPase inhibitor activity (GO:0005095),-0.3639679023663917,-0.9263646038028938,0.5435897435897435,0.8642605706213006,1.0,5/13,13.26%,SLIT2;IQGAP2;IPO5;CPEB2;RTKN
prerank,carbohydrate:cation symporter activity (GO:0005402),0.436137185177668,0.9243464557801773,0.5623931623931624,0.9248410644771112,1.0,2/11,8.42%,SLC5A10;SLC2A9
prerank,general transcription initiation factor binding (GO:0140296),0.3787138674333682,0.9237400299460632,0.5660919540229885,0.9228635093560069,1.0,10/25,18.51%,HHEX;BRF2;GTF2A1;PSMC1;TAF1B;PSMC5;TAF11;ESR1;DRAP1;RELA
prerank,cytokine receptor activity (GO:0004896),0.3133474512762494,0.9235600996338145,0.594847775175644,0.9201435949329098,1.0,9/83,7.41%,CCR1;LIFR;IFNGR1;CSF2RB;IL17RD;IFNAR1;IL1RAP;CMKLR1;IL20RB
prerank,cation transmembrane transporter activity (GO:0008324),0.3370235612306246,0.9233681578070388,0.5523932729624839,0.9174289205139589,1.0,4/48,8.63%,SLC6A6;SFXN1;SLC7A1;SLC15A4
prerank,G protein-coupled receptor activity (GO:0004930),0.2877689381536206,0.9203237164766817,0.6515463917525773,0.9208131373395859,1.0,26/239,12.94%,ADGRL4;S1PR1;ADGRE5;F2RL1;ADRB2;RRH;LGR5;GPR157;QRFPR;LANCL1;MRGPRE;LPAR6;GPR143;HCRTR1;NPR1;MC4R;CMKLR1;MTNR1B;ADGRA1;ELOVL4;ADGRB1;GLP1R;XPR1;GRM5;CX3CR1;GPR26
prerank,vitamin D receptor binding (GO:0042809),-0.36776912866036743,-0.9200750786196854,0.5527777777777778,0.8739838179202605,1.0,5/14,15.65%,SNW1;MED13;MED14;MED16;TAF7
prerank,neuropeptide receptor binding (GO:0071855),0.42360528217325305,0.9198634001783058,0.5642737896494157,0.9186558581623988,1.0,4/14,23.17%,GAL;APLN;NMU;NTS
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.28730192034582386,0.91931582390774,0.6151385927505331,0.9167396311900702,1.0,42/181,20.26%,LDB2;LMO2;TBXT;TAL1;HNF4A;ACTN4;RBBP8;HEY2;KLF4;BBS7;COMMD7;GABARAPL1;STAT1;HSPB1;RBL1;NFE2L2;JUN;TCF3;DHX9;MAD2L2;NFKBIA;ACTB;NPM1;HIF1AN;DMAP1;DTX3L;TBX20;HIF1A;NFATC1;CTNNB1;DUSP26;SPEN;MAPK14;SIN3A;TBX6;RELA;CRY1;MEF2A;NCOA7;JUP;DNAJA1;GSK3B
prerank,chloride channel activity (GO:0005254),0.3251087218260247,0.9190726194595177,0.6009913258983891,0.9141297071402282,1.0,14/59,19.81%,CLIC4;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;GABRA2;GABRE;GLRA2;GABRG3;GABRB1;CLCN7
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.382064530878777,-0.9182791242491684,0.5757575757575758,0.8726318287796501,1.0,5/11,25.39%,NAA60;NAA40;NAA50;NAA10;NAA15
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.38300119922873993,0.9164667087964462,0.5424242424242425,0.9167684231565322,1.0,8/22,20.23%,LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1;SYT1;DNAJA1
prerank,SUMO binding (GO:0032183),0.4250193647902095,0.9144157339172675,0.6006711409395973,0.9180349424994146,1.0,4/13,18.76%,HERC2;CASP8AP2;HABP4;USPL1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.39648746932270973,-0.9142815316438659,0.6010362694300518,0.8763598432164718,1.0,2/10,9.61%,DSE;RENBP
prerank,histone deacetylase binding (GO:0042826),-0.23701203351731556,-0.9141316363090363,0.6981132075471698,0.8708905345161666,1.0,20/88,15.35%,GLI3;CHD4;PRKN;TOP2B;NIPBL;KAT2B;NUDT21;DACT1;LCOR;CAMTA2;NACC1;BHLHE41;ZMYND15;HDAC4;HDAC1;AKAP8L;HDAC6;SIRT2;MTA2;BCOR
prerank,phosphatase inhibitor activity (GO:0019212),-0.32117565560093914,-0.9139034375647199,0.5821325648414986,0.8657322507094898,1.0,3/20,4.38%,PTN;SET;BOD1L1
prerank,lipase activity (GO:0016298),0.3364572225810765,0.9109289781899699,0.5849802371541502,0.922577347316208,1.0,4/43,8.33%,PITPNM3;PNLIP;LCAT;ABHD6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4310112435041705,0.9081358377325242,0.5709515859766278,0.925740726927259,1.0,4/11,22.38%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.3708350239890854,0.9065026468967144,0.5546995377503852,0.9259696140390672,1.0,8/24,22.78%,DAB2IP;CERT1;PLEKHA5;ARFIP2;GOLPH3L;GOLPH3;PLEKHA3;OSBPL5
prerank,metallocarboxypeptidase activity (GO:0004181),-0.3058681537898036,-0.9064808273219158,0.6261398176291794,0.877625592467761,1.0,8/26,18.89%,AEBP1;CPE;AGBL3;CPXM2;CPXM1;AGBL1;CPA6;ACE2
prerank,mRNA methyltransferase activity (GO:0008174),0.42654088924874844,0.9049224344815638,0.5704584040747029,0.926144953892463,1.0,3/12,13.27%,TRMT61A;TRMT61B;METTL14
prerank,vinculin binding (GO:0017166),0.4388579376453635,0.9040885878352979,0.5874363327674024,0.9248186033518334,1.0,3/11,12.53%,UTRN;CTNNA1;SORBS3
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.40337951193435295,0.9011461894131089,0.5691823899371069,0.9278908328496542,1.0,3/16,12.22%,PIR;HGD;ALOXE3
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.23195226456930876,-0.9011232157909443,0.6968085106382979,0.884609651163262,1.0,25/83,21.74%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,endopeptidase regulator activity (GO:0061135),0.3327538332538302,0.9008922671144842,0.5903954802259888,0.9253858859477965,1.0,11/40,22.35%,RECK;APH1A;SPINT2;VSIR;PSMD14;SLPI;CST3;PROS1;APH1B;USP14;A2M
prerank,ATP hydrolysis activity (GO:0140603),0.34060111718324787,0.9008471593600629,0.5943396226415094,0.9224320590192719,1.0,7/41,11.83%,MYO1E;DDX4;KIF26A;HSPA1B;DHX9;ABCG4;CLU
prerank,Wnt-activated receptor activity (GO:0042813),0.4083412529949199,0.9006663833890358,0.5993485342019544,0.9197854048873129,1.0,5/15,14.82%,FZD6;TSPAN12;LRP5;FZD9;FZD3
prerank,Hsp90 protein binding (GO:0051879),0.35163011674297684,0.8973478728965297,0.5504322766570605,0.9237744898212805,1.0,8/33,19.18%,NOD2;UNC45B;PTGES3;UNC45A;HIF1A;AHSA1;PPID;ERN1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.37287046119998185,-0.8954106599837627,0.5801526717557252,0.8920142919891618,1.0,8/11,53.60%,CHRNB1;CHRNA4;CHRNB2;CHRNA9;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,N-acetyltransferase activity (GO:0008080),0.3844354473085399,0.8948640407126928,0.5654135338345865,0.9258087775338715,1.0,1/19,1.42%,SATL1
prerank,G protein-coupled receptor binding (GO:0001664),0.2895442548579352,0.8943803510369837,0.6517857142857143,0.9239117432303288,1.0,10/132,8.00%,CCDC88C;S1PR1;ACE;GNAQ;GNAL;HOMER2;GNAI2;HSPA1B;ARRB1;REEP2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.3842873707835894,-0.8915892995120038,0.6044226044226044,0.8950895558634927,1.0,5/10,20.13%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.36254092613144057,0.8872470545556969,0.6044776119402985,0.9356315299055421,1.0,3/26,7.47%,SLC6A6;SLC16A2;SLC16A4
prerank,thyroid hormone receptor binding (GO:0046966),-0.28746598251190597,-0.8837281735725516,0.6193548387096774,0.90715871057039,1.0,10/28,19.63%,TRIP12;TACC1;NSD1;MED13;JMJD1C;GTF2B;MED16;TAF7;GTF2H1;GAS2L1
prerank,manganese ion binding (GO:0030145),0.3282295765826181,0.8817639546491798,0.6456692913385826,0.9437291707903361,1.0,11/48,12.01%,POMGNT1;MGAT5;ARG1;PCK2;EXD2;MTPAP;FEN1;ADPRM;MGAT1;XXYLT1;GALNT4
prerank,potassium channel regulator activity (GO:0015459),0.3180823096592292,0.8801417962575289,0.6393659180977543,0.9439825725533711,1.0,7/49,12.11%,KCNE3;ADRB2;DPP6;DPP10;SGK1;NEDD4L;ARPP19
prerank,UDP-glycosyltransferase activity (GO:0008194),0.305007794519814,0.876705854399704,0.6474278544542033,0.947899183820846,1.0,7/70,8.01%,GCNT1;MFNG;POMGNT1;EXT1;GCNT2;POGLUT1;B3GNT3
prerank,cation:chloride symporter activity (GO:0015377),-0.3709337376558933,-0.8762731382158271,0.6462264150943396,0.9184570169728871,1.0,2/10,6.05%,SLC12A2;SLC6A1
prerank,nucleobase-containing compound kinase activity (GO:0019205),-0.32499896321600746,-0.8759106586418811,0.6045918367346939,0.9135608778812458,1.0,9/17,33.09%,AK5;CMPK2;AK1;NME2;NME6;NOL9;AK3;NME1;AK9
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.3289528033992335,0.8756489631278379,0.6217331499312242,0.9470467313322075,1.0,4/38,8.37%,HIP1;DAB2IP;TECPR1;PLEKHA5
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.40200232091138766,0.8753462604956773,0.6037414965986394,0.9445964105878959,1.0,3/13,8.63%,SLC7A7;SLC7A1;SLC15A4
prerank,protein-lysine N-methyltransferase activity (GO:0016279),-0.2742728203624752,-0.8749061660715497,0.6891385767790262,0.9100262947791905,1.0,11/34,18.11%,NSD3;EHMT1;SETD7;DOT1L;METTL21A;KMT5B;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2
prerank,protein kinase activator activity (GO:0030295),0.309936487276644,0.874809921451288,0.6459948320413437,0.9426478743573334,1.0,15/60,19.75%,AFAP1L2;IQGAP1;MADD;IRGM;GPRC5A;GRM5;MARK2;CALM3;PAK2;RICTOR;DAXX;EPO;CD24;MAP2K1;CAB39
prerank,nuclear import signal receptor activity (GO:0061608),-0.3351610299989264,-0.8744169936503664,0.6148148148148148,0.9056304548926046,1.0,5/15,14.90%,KPNA1;TNPO3;RANBP6;IPO5;TNPO2
prerank,RNA binding (GO:0003723),0.26001762769540004,0.8734380240395591,0.93,0.9424406483539362,1.0,388/1321,24.57%,NANOS1;NANOS3;SORBS2;SYNE1;FASN;ESRP2;NOVA2;ZYX;FLNB;FKBP4;ADARB1;MACF1;RBPMS;IFIH1;LRRFIP1;VIM;MAP4;NPM3;BOP1;DHX32;DIAPH1;ACTN4;PELP1;KCTD12;TLR3;RPS21;RPL27;DDX4;TNS1;PUM2;MSN;RBM7;CCDC9B;SUMO2;SRP14;MBNL1;DHX37;ZCCHC9;SSBP1;DDX39A;KARS1;DDX41;RPL7;MRPL4;PPIE;MEX3B;MYEF2;KHDRBS3;APEX1;PHF6;MYH9;ASS1;FNDC3B;PABPC5;RTF1;BUD13;TUBB4B;PSMD4;LSM1;SETX;ENDOV;PLEC;HNRNPA0;ZC3H12A;MRPL41;ELAVL1;RANGAP1;NGRN;HSPB1;HSP90B1;HSPA1B;CCDC124;AATF;PURA;CTNNA1;KPNB1;EXOSC3;ATP5F1A;MTPAP;ZNF346;NVL;DNAJC2;U2SURP;ZC3H7A;OAS2;DCP1B;MRPS31;SCAF4;POLR2G;RPS14;MRPL1;RPS27A;RBM28;RPL35;ETF1;DDX28;ADAR;CACTIN;EIF3B;JUN;DSP;ZFP36L2;WDR46;RTN4;HMGB1;RPL21;DHX9;DKC1;HSPE1;CELF4;DUSP11;TRIM25;PRPF38A;TASOR;POLR2D;MRPL15;EIF1AX;EIF1;RPL37;ARHGEF1;FARS2;CNOT1;RPS28;RPL34;LARP1B;TUFM;HNRNPK;GTPBP1;AGO4;PTPN1;RPS9;XRN2;FIP1L1;ALKBH8;NPM1;EEF2;PTBP3;CAVIN1;ASCC3;PCBP1;BRCA1;MRPL23;TIAL1;RPS25;EIF3I;RBM11;ILF2;DHX40;GLRX3;HELZ2;VIRMA;NHP2;MARK2;CHTOP;RPL30;EIF3G;GCN1;NUFIP2;CCT4;TRMT2A;MSI2;SMNDC1;METAP2;FBLL1;SRSF9;RPS5;XRN1;RPL27A;AKAP1;GPATCH4;NOL8;FXR1;RPP38;RBM45;METTL14;HABP4;SRP9;DDX56;DDX21;NOL3;CLNS1A;HNRNPH2;FASTKD5;PSMC1;SART1;MRPL14;MRPL32;MRPS12;TFB2M;RAN;RPL23A;ELAVL2;COL14A1;TRMT10B;NUP42;SYF2;HMGB2;SF3B4;MAP3K20;CCT6A;RPS15;SRPRA;EIF3A;CRNKL1;EIF2S1;EIF2A;PIN4;RPL19;DDX55;EDC3;FAU;RPS18;YBX1;MRPL39;DDX6;RPL32;TEFM;RACK1;PTCD2;MTIF2;EIF3H;SLPI;PKN2;TCOF1;DHX38;SF3A1;ELAC2;UBFD1;SPEN;RBM15;TMSB4X;UTP18;ATXN2L;DROSHA;RPL37A;RPL18A;HADHB;LRPPRC;RPL22L1;MRPL54;EXD1;SRPK1;UNC50;POLDIP3;RPL7L1;TRNAU1AP;SEPSECS;SAFB2;NSUN5;TRMT1L;EXOSC9;TUT7;POP1;KHNYN;DXO;SPTBN1;LAS1L;RSRC2;CCDC47;DDX39B;RPUSD2;LSM14B;TIA1;NOL4;CSTF2;MKRN1;SRP19;DDX47;PTBP2;TDRD9;ZC3H15;MRM3;G3BP1;HNRNPUL1;SF3B6;NAP1L4;DCAF13;FTSJ3;LSM2;ZC3HAV1;MYO18A;IBA57;MKRN2;BARD1;PA2G4;MRPS30;DARS1;GFM1;ZC3H8;ANG;SMG7;SYNCRIP;RRP9;PPHLN1;YTHDC1;CPSF3;MRPL11;NOL7;STAU2;ACAA2;RCAN3;PWP2;C1D;SF3B2;TRMT1;DHX58;RSL24D1;ANKRD17;BAG4;RPL18;MRPS35;MRPS28;EIF2AK2;RPL39;SF3A3;MTCL1;IMP4;ZFP36L1;MBNL2;NSUN6;UBA1;CRKL;RPS19;NOLC1;EXOSC10;ZCCHC17;MRPS9;CSDE1;HEXIM1;FAM50A;RPL31;RPS8;LRRC47;JAKMIP1;NSRP1;RTCA;MEX3D;NOP53;ZNF106;EXOSC1;UBAP2;NQO1;FBL;SEC63;MRPS27;URB1;RPF2;TYW5;EDF1;ZNF638;NUDT16;TOP3B;TBRG4;KIN;ZCRB1;CNBP;TSFM;EIF4G1;WDR43;TCP1;POLR2B;DHX36;DHX57;PATL2;CPNE3;IREB2;HLTF;ZNF326;PRPF40B;UBE2O;FRG1;TUBA1B;ANXA11;CCT3;LRRC59;RPL3;RAE1;OASL;UTP20;OTUD4;USO1;EIF4ENIF1;RIMS1;MYO5A;MRTO4;GRN;PRPF6;ALYREF
prerank,E-box binding (GO:0070888),0.3370644823491791,0.8727508876750942,0.6285310734463276,0.9409204963174407,1.0,5/34,9.35%,NEUROG2;TAL1;GATA3;SNAI2;TCF3
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.4099452668042074,0.871419653380875,0.6362098138747885,0.9406954391377658,1.0,4/12,22.38%,SLC17A9;SLC35B3;SLC25A25;SLC25A42
prerank,protein kinase C activity (GO:0004697),0.39267865051502965,0.8691016790251281,0.6238244514106583,0.9423742278716035,1.0,3/14,10.21%,PRKD1;PKN1;PRKCG
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.3550056855192598,-0.8689743348514535,0.6215538847117794,0.912228406174763,1.0,4/12,21.71%,DHRS4;AIFM2;NDUFS7;CRYZ
prerank,hormone receptor binding (GO:0051427),0.38692836590531426,0.8641506583058782,0.6302521008403361,0.9488051820129602,1.0,3/14,18.21%,JAK2;NPPC;NCOA6
prerank,chemokine activity (GO:0008009),-0.2715330173258471,-0.8638010072475389,0.694078947368421,0.9176732646464221,1.0,23/31,51.87%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8;CCL1;CCL3;XCL1;CXCL13;CXCL2;CCL13
prerank,DNA replication origin binding (GO:0003688),0.35284075003462273,0.8637538556630058,0.6348733233979136,0.9466397558447436,1.0,5/23,15.09%,ORC3;DHX9;POLA1;ORC5;KAT7
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.26984010178305534,-0.8610938663580116,0.6777408637873754,0.9178420529586989,1.0,4/31,6.36%,SLC12A2;KCNK5;ABCC9;KCNQ4
prerank,steroid hydroxylase activity (GO:0008395),0.37752594239618326,0.8561208149790004,0.650231124807396,0.9581386816315928,1.0,1/16,2.19%,CYP39A1
prerank,thioesterase binding (GO:0031996),0.41950136590719994,0.8548293255717907,0.6384083044982699,0.9576736431101271,1.0,2/11,10.68%,TRAF1;RAC1
prerank,store-operated calcium channel activity (GO:0015279),0.41740726034528836,0.8540913718913538,0.6136752136752137,0.956106235238217,1.0,4/10,14.44%,ORAI1;STIM2;TRPC7;TRPC5
prerank,bHLH transcription factor binding (GO:0043425),-0.30629828231598094,-0.8531512598885201,0.6629834254143646,0.928523873931231,1.0,4/19,11.10%,FHL2;CREBBP;SMAD3;BHLHE41
prerank,zinc ion binding (GO:0008270),0.2608486291981011,0.8521799912234407,0.8104508196721312,0.9569592831466824,1.0,39/293,12.28%,MYRIP;ACE;CRIP2;GDA;ARHGEF2;DUSP12;MSRB3;KLF7;IFIH1;GCH1;KLF4;LANCL1;TNFSF10;SHANK3;RNF125;SMPDL3A;ASAH2;ARIH1;PGGT1B;TRIM24;CLIP1;KPNB1;MT2A;PLSCR1;GRIN2B;CAD;MBD1;KMT2B;DHH;EGR1;PTPN1;TET3;TAB2;TNKS;ALKBH8;HIF1AN;SAP30L;TRIM8;SUV39H2
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2987799661414291,-0.8513126257577307,0.6931506849315069,0.9266443448841634,1.0,7/20,24.77%,CASK;AK6;MAGI3;CMPK2;AK1;LRGUK;DLG1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.298452080894395,-0.8506201418517289,0.6491228070175439,0.9225683551095057,1.0,7/20,17.92%,USP9X;UFSP2;SENP3;USP50;SENP1;OTULINL;SENP2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.41264248037375073,0.848172756806444,0.643979057591623,0.9617580185941873,1.0,1/10,1.85%,GDA
prerank,voltage-gated cation channel activity (GO:0022843),0.28316072567722567,0.8478859503595751,0.7127906976744186,0.9593838346111362,1.0,18/97,17.87%,KCNQ1;KCNH8;CACNA1A;KCNG3;GRIN2B;KCNC1;KCNH7;GRIN2C;TPCN2;GRIN3A;KCNC4;KCNA1;CACNA1E;KCNC2;KCNH5;KCNH1;GRIN2A;KCNQ3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3959500569315946,0.8468359866402334,0.6586921850079744,0.9583836193387095,1.0,6/13,17.88%,SH3BP4;ARHGDIA;CCDC88A;RANBP1;ITGB1BP1;GDI1
prerank,poly(A) binding (GO:0008143),-0.2978994997541401,-0.8462175232588353,0.6717325227963525,0.9259136108057497,1.0,2/21,1.44%,RBMS3;RBMS1
prerank,ribonuclease activity (GO:0004540),0.29723124781139365,0.8459565587992876,0.7006622516556291,0.9571788870964077,1.0,22/56,24.62%,INTS11;ZC3H12A;EXOSC3;RNASE1;EXOSC8;RNASE6;EXOG;ELAC2;NOB1;EXOSC9;KHNYN;RNASE12;ERN1;ANG;RNASE4;CPSF3;EXOSC10;DIS3L2;EXOSC1;RNASEH2A;RNASE7;RNASEH1
prerank,carboxypeptidase activity (GO:0004180),-0.2644110483492485,-0.8449608735139934,0.7582417582417582,0.9230601506661553,1.0,9/35,18.89%,AEBP1;CPE;AGBL3;CPXM2;NAALAD2;CPXM1;AGBL1;CPA6;ACE2
prerank,diacylglycerol kinase activity (GO:0004143),0.40209838742991566,0.841455126033561,0.6412859560067682,0.962726212757405,1.0,5/11,25.02%,DGKH;AGK;DGKI;DGKA;DGKB
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2836210564608025,0.8410317690403118,0.7141133896260555,0.960575235354875,1.0,22/85,23.73%,AOAH;PNLIP;LCAT;PGAP1;PNPLA6;APMAP;ABHD6;GDPD1;ACHE;PON2;PON3;ABHD2;PLA2G12A;PLAAT3;BCHE;PNPLA2;ABHD4;LYPLA1;MGLL;ESD;GDE1;LYPLAL1
prerank,retinoid X receptor binding (GO:0046965),0.39192926648594173,0.8382483922826754,0.646551724137931,0.9627371969433512,1.0,2/11,9.81%,NR4A2;ARID5A
prerank,histone methyltransferase binding (GO:1990226),0.3905537808316758,0.8371475616572266,0.6475548060708263,0.9619499719243187,1.0,3/11,16.33%,LCORL;CTNNB1;CBX1
prerank,GDP binding (GO:0019003),0.291873277265102,0.8339137819964683,0.7094763092269327,0.9652139078613013,1.0,18/63,22.09%,KRAS;NRAS;RRAS;RAB35;RRAGD;RHEBL1;RRAS2;RAN;RHEB;RAB27B;RIT2;RAB27A;RAB5C;RRAGC;RAB31;RAB12;RALB;RAP1B
prerank,hexosyltransferase activity (GO:0016758),0.2784823213654061,0.8338033473872983,0.7377049180327869,0.9625218495296143,1.0,9/101,8.21%,GCNT1;MFNG;POMGNT1;B4GALT4;EXT1;GCNT2;POGLUT1;B3GNT3;A4GALT
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.3771478393252732,0.8335182265170745,0.662379421221865,0.9600984413398433,1.0,4/13,23.27%,DDT;ECI1;SREBF2;IDI1
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.25608447536629586,-0.8305680959414977,0.7631578947368421,0.9458601198852045,1.0,8/31,16.92%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,protein kinase inhibitor activity (GO:0004860),-0.2439416316441789,-0.8298243797955099,0.7579365079365079,0.9416637093781381,1.0,14/42,22.92%,PARVA;DNAJC3;DUS2;SPRED1;SPRED2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1;IBTK;CIB1;TAOK3;GSKIP
prerank,ionotropic glutamate receptor binding (GO:0035255),0.4144407816328476,0.8294350453299432,0.687392055267703,0.964627472240388,1.0,4/10,19.90%,SHANK3;SHISA6;NSF;SHANK2
prerank,NF-kappaB binding (GO:0051059),0.338429676138047,0.8291575382919372,0.6818851251840943,0.9622698933481597,1.0,8/24,25.64%,COMMD7;NFKBIA;NPM1;HIF1AN;RELA;GSK3B;RNF25;HDAC2
prerank,poly-purine tract binding (GO:0070717),-0.2714554876642217,-0.8288052248832372,0.7311475409836066,0.9381573826061491,1.0,12/27,27.35%,RBMS3;RBMS1;DAZAP1;DDX1;DDX3X;HNRNPU;PABPC1;PABPC4L;KHDRBS1;EIF4A3;HNRNPDL;PNPT1
prerank,nuclear localization sequence binding (GO:0008139),0.34720024702030294,0.8264263406320657,0.6741573033707865,0.9643506943333371,1.0,7/18,21.92%,KPNB1;NFKBIA;NUP153;KPNA3;CABP1;IPO4;BRAP
prerank,MAP-kinase scaffold activity (GO:0005078),0.39897673377595905,0.8259292962166109,0.6758508914100486,0.9623694029670334,1.0,2/11,5.67%,IQGAP1;SPAG9
prerank,motor activity (GO:0003774),0.2894680031603849,0.8238038131711505,0.7264516129032258,0.9634790304831774,1.0,11/60,15.66%,MYO1E;KIF26A;MYH9;KIF2A;MYL6;STARD9;PIN1;KIF24;KIF26B;KIF16B;KIF1A
prerank,deoxyribonuclease activity (GO:0004536),0.3696756173143059,0.8217852646784901,0.6821963394342762,0.9642996924042381,1.0,3/14,13.69%,APEX1;DFFB;ERCC4
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.35967805844239853,0.8197598623260165,0.684887459807074,0.9622670815063255,1.0,2/16,7.57%,ANO6;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),0.35967805844239853,0.8197598623260165,0.684887459807074,0.9622670815063255,1.0,2/16,7.57%,ANO6;TTYH3
prerank,lipoprotein particle receptor binding (GO:0070325),0.33013666644625667,0.8183934793805434,0.6789940828402367,0.9618564538444734,1.0,7/27,14.10%,APOA1;LANCL1;HSP90B1;AP2M1;CLU;MESD;LDLRAP1
prerank,dynactin binding (GO:0034452),-0.3336633905814762,-0.815863257015464,0.6864197530864198,0.9578176308972296,1.0,3/12,19.11%,SNX6;BICD2;SNX5
prerank,G protein-coupled peptide receptor activity (GO:0008528),-0.21559429832960583,-0.8124744388192423,0.8756476683937824,0.9586389011326534,1.0,30/73,34.47%,LGR4;NPR3;EDNRA;SORCS2;BDKRB2;SORCS3;PTH1R;CYSLTR1;EDNRB;CYSLTR2;MC5R;GPR37L1;GLP2R;OPRK1;APLNR;VIPR2;CALCRL;CCKBR;NPSR1;TSHR;GALR1;S1PR2;LHCGR;GPR37;F2R;GRPR;PTH2R;KISS1R;GIPR;MAS1
prerank,magnesium ion binding (GO:0000287),0.26416625382511183,0.8118749149915043,0.7833894500561167,0.970536154133796,1.0,44/135,24.28%,SNRK;OXSR1;CDC42BPA;MAP3K6;CDC42BPG;STK38;STK38L;NLK;THTPA;EXD2;ENDOV;MAST1;SIK2;LRRK2;MTPAP;PLSCR1;FEN1;XXYLT1;GSS;MARK2;RAN;RHEB;MAP3K20;SRPK1;CIB2;DXO;ERN1;PLSCR3;RRAGC;AASDHPPT;CDC42BPB;NT5C3A;ABL2;DIS3L2;GEN1;NUDT16;IDH3G;DHX36;MVK;BRSK2;WRN;MTHFD2;TESC;PPA2
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3513747784521707,-0.8110882765898546,0.6955503512880562,0.9556908295119793,1.0,4/10,9.30%,DPP4;FAP;PRCP;NAALAD2
prerank,semaphorin receptor activity (GO:0017154),0.38927765042500123,0.810822884990127,0.7011686143572621,0.9696569386099336,1.0,2/11,3.97%,PLXNA4;PLXND1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.32361390105075927,-0.8085342690179154,0.7225,0.9551246298798886,1.0,2/13,5.00%,AGPAT4;LPCAT2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.33413735963465546,-0.8067592567903494,0.7305699481865285,0.9530470980828741,1.0,1/11,0.37%,EGFR
prerank,lipase activator activity (GO:0060229),0.3903476321382691,0.8050684594567769,0.6942567567567568,0.9766968698219367,1.0,3/10,14.00%,FYN;BTK;APOH
prerank,MAP kinase activity (GO:0004707),-0.31518969861094437,-0.8041196560582482,0.701058201058201,0.9525312425099832,1.0,2/14,7.38%,MAPK4;MAPK6
prerank,phospholipase A2 activity (GO:0004623),-0.26754650901933547,-0.8031514555115744,0.7617554858934169,0.9488798451235799,1.0,15/26,47.48%,PLA2G4A;PLA2G15;PLA2G6;PLA2G4C;PLA2G7;PLA2G4F;PLAAT1;PLA2G4B;PLA2G5;PLB1;ABHD3;PLA2G3;PLAAT5;PNPLA3;PLA2G4E
prerank,beta-tubulin binding (GO:0048487),0.31257654187004813,0.8010954209504112,0.7234352256186317,0.980690421632287,1.0,4/31,9.10%,TRPV4;TTLL7;GABARAPL1;UXT
prerank,histone methyltransferase activity (GO:0042054),-0.24981897676837328,-0.7962583499577681,0.7828947368421053,0.9560347432181467,1.0,8/32,16.43%,NSD3;KMT2C;EHMT1;SETD7;DOT1L;KMT5B;SUV39H1;N6AMT1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.27071324092147697,0.794802674629345,0.7682619647355163,0.9885650519903721,1.0,20/78,21.84%,CASP8;USP38;CASP2;CASP1;USP12;CAPN5;USP29;USP9Y;CASP7;PYCARD;USP35;CTSK;CTSO;CAPN1;MALT1;CTSH;USP47;CAPNS1;USP14;USP30
prerank,GABA receptor binding (GO:0050811),0.37818770832637383,0.7939290675418922,0.7278797996661102,0.9872247489120844,1.0,2/11,6.18%,AKAP5;GABARAPL1
prerank,ubiquitin-specific protease binding (GO:1990381),0.33864191391972226,0.7873798684885356,0.7352941176470589,0.9957321891466335,1.0,3/19,13.00%,SPATA2;BAG6;CHMP3
prerank,deubiquitinase activity (GO:0101005),-0.20038449151528334,-0.7865670490133272,0.8932584269662921,0.9674489652361126,1.0,25/88,21.74%,USP33;USP20;USP9X;USP13;USP11;USP50;USP1;USP3;MINDY3;OTUD6B;OTUD7B;USP22;UCHL1;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1;USP34;VCPIP1;JOSD2;USP2;TNFAIP3;USP46;USP31
prerank,ADP binding (GO:0043531),-0.26391018391413246,-0.7826853636991958,0.7852760736196319,0.9686165602448202,1.0,5/25,13.17%,PRKAG2;ME1;GCLC;MYO9B;MSH6
prerank,estrogen receptor binding (GO:0030331),0.30773462380811745,0.7817801662730426,0.7571428571428571,1.0,1.0,12/32,19.37%,LEF1;SRARP;ARID5A;CNOT1;CTNNB1;ESR1;MMS19;NCOA6;STRN;PPID;DCAF13;WBP2
prerank,epidermal growth factor receptor binding (GO:0005154),0.3132226489459554,0.7795175974147405,0.7271364317841079,1.0,1.0,3/25,10.33%,HIP1;PLSCR1;CCDC88A
prerank,hormone activity (GO:0005179),0.2751415412118887,0.779428780157389,0.7850589777195282,1.0,1.0,7/54,19.39%,EDN1;GAL;NPPC;APLN;SST;PENK;VGF
prerank,ubiquitin binding (GO:0043130),-0.20266642721895348,-0.7784669654283307,0.9154929577464789,0.9700503089374239,1.0,31/73,30.61%,PRKN;USP33;UBE2N;SMAD3;USP13;UBXN7;RNF31;UBXN2B;DNAJB2;TSG101;UCHL1;MDM2;OTULINL;SIRT2;SHARPIN;UBE2L6;UBAP1;TNFAIP3;RNF168;GGA3;TOLLIP;UBXN11;TOP2A;MVB12B;NEDD4;N4BP1;AUP1;RAD23A;NUP62;BIRC2;OTUB2
prerank,copper ion binding (GO:0005507),0.291278169593415,0.7773137063002635,0.7645466847090663,1.0,1.0,12/42,22.31%,ATOX1;SNCG;ATP7A;IL1A;TYR;PRNP;CUTA;HEPH;ATP7B;ANG;CCS;SOD1
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.25645137920016076,-0.7758358709324907,0.8241042345276873,0.9689894985244505,1.0,13/27,28.24%,PPARA;PRKN;DCUN1D3;ARIH2;UBE3D;RNF180;DCUN1D4;ZMYM2;SIAH1;TOLLIP;FOXL2;SIAH3;AUP1
prerank,sterol transfer activity (GO:0120015),0.33442394241895346,0.7755099136058425,0.7142857142857143,1.0,1.0,2/17,5.63%,APOA1;PLTP
prerank,nucleotidyltransferase activity (GO:0016779),-0.2758217760834624,-0.7746614974958406,0.7700534759358288,0.9657276923416427,1.0,8/19,21.02%,CRPPA;REV1;TENT4B;TERT;TUT1;PAPSS2;TUT4;CGAS
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.27648532091617684,0.7742203971723983,0.7910828025477707,1.0,1.0,11/60,14.97%,DUSP1;LRRC39;PPM1F;LRRK2;PPP3CA;PP2D1;CDC14A;PDP1;PPM1D;PPM1L;PPP2CB
prerank,ion gated channel activity (GO:0022839),-0.2596472216327263,-0.7722484482221725,0.825,0.9643261820800851,1.0,3/24,8.27%,KCNT2;ANO1;KCNT1
prerank,cholesterol transfer activity (GO:0120020),0.3390057278178965,0.7708730280840592,0.7261345852895149,1.0,1.0,2/16,5.63%,APOA1;PLTP
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.3756612491530935,0.770794101214346,0.727580372250423,1.0,1.0,6/10,20.39%,SETD3;ASH1L;NSD2;PRDM9;SETD2;SMYD2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.30121082586266107,0.7703935454858674,0.7720797720797721,0.9986868504100586,1.0,11/30,23.50%,ATP7A;SLC31A1;SLC30A1;SLC39A6;SLC25A28;ATP7B;SLC30A3;SLC39A3;SLC30A4;SLC39A12;TTYH1
prerank,secondary active transmembrane transporter activity (GO:0015291),0.27979689061078605,0.7694610751621798,0.775483870967742,0.997394330376593,1.0,7/51,9.52%,SLC25A16;SLCO1C1;SLC35D2;SLC35E4;SLC16A2;CLCN3;SLC25A30
prerank,mRNA binding (GO:0003729),0.2382909975599526,0.7688651524207628,0.9041666666666667,0.9957055823309847,1.0,26/249,11.45%,NANOS1;NANOS3;ESRP2;NOVA2;ADARB1;RBPMS;PUM2;RPL7;PPIE;MYEF2;KHDRBS3;PABPC5;HNRNPA0;ZC3H12A;ELAVL1;DCP1B;RPS14;RPL35;ETF1;ELAVL4;DHX9;CELF4;HNRNPK;ANGEL2;PTBP3;PCBP1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.3494895107370304,0.7664304041019293,0.7212837837837838,0.9967049045842604,1.0,5/14,28.38%,CAPN5;CAPN1;CAPNS1;CAPN10;CAPN2
prerank,O-acyltransferase activity (GO:0008374),0.3032910671443361,0.7663885394030374,0.7774687065368567,0.994048521437166,1.0,5/30,10.81%,MBOAT2;LPCAT4;LCAT;LPCAT3;MOGAT1
prerank,nuclear receptor binding (GO:0016922),0.2526974482116902,0.7646757545541581,0.8528389339513326,0.993881484063074,1.0,29/111,19.37%,NR4A2;ACTN4;LEF1;SRARP;PKN1;BRD8;KDM3A;STAT1;FOXP1;ARID5A;CNOT1;NR4A1;MED30;YWHAH;HIF1A;CTNNB1;MED17;MED4;TAF11;ESR1;DAXX;MMS19;NCOA6;STRN;CRY1;PPID;DCAF13;NCOA7;WBP2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.23124731678915952,-0.7611982197501072,0.8456140350877193,0.9762899940560866,1.0,8/34,16.92%,UBE2E2;UBE2N;TAF1;BIRC6;UBE2L3;UBE2G2;UBE2QL1;UBE2L6
prerank,signaling receptor complex adaptor activity (GO:0030159),0.28827855860580515,0.7604581360692388,0.7849462365591398,0.9978590710378672,1.0,6/38,9.11%,SPATA2;CARD10;SHANK3;SPAG9;LRRK2;STAP1
prerank,telomeric DNA binding (GO:0042162),0.30063604145527095,0.7601144246315963,0.7810734463276836,0.995680027181836,1.0,11/32,24.06%,HMBOX1;ZBTB48;APEX1;PURA;STN1;CTC1;TERF2IP;SMG7;BLM;TERF2;WRN
prerank,nuclease activity (GO:0004518),0.26949402217652324,0.7588023240503272,0.810077519379845,0.9950205612348901,1.0,19/52,26.06%,APEX1;ZC3H12A;PLSCR1;DFFB;FEN1;RNASE1;XRN2;RNASE6;EXOG;RNASE12;ANG;RNASE4;DIS3L2;RNASEH2A;WRN;RNASE7;RNASEH1;ISG20L2;OGG1
prerank,protein kinase regulator activity (GO:0019887),0.25315110307752464,0.7578237779084935,0.8374269005847953,0.9939003391578888,1.0,20/95,19.75%,CCNY;CCND2;CCND3;CCNE1;SMCR8;MADD;ELP4;GPRC5A;APC;NPM1;MARK2;SPRY4;CSNK2B;SH3BP5L;NCK1;DAXX;CXCL10;EPO;ELP3;CAB39
prerank,hyaluronic acid binding (GO:0005540),0.3601733535385084,0.7575695082275814,0.7495934959349594,0.9915995407039628,1.0,2/10,5.51%,HYAL2;LAYN
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.28995446484866205,-0.7556667797627133,0.7917808219178082,0.9791576777489912,1.0,5/15,35.75%,PLA2G4A;PLA2G4C;PLA2G4F;PLA2G4B;PLA2G5
prerank,sulfotransferase activity (GO:0008146),0.29511782366843936,0.7547986352261479,0.7908309455587392,0.9930764993884563,1.0,4/33,6.88%,HS3ST1;CHST14;SULT6B1;CHST11
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2548111070173639,-0.754481300062384,0.8653846153846154,0.9758228483378438,1.0,7/24,20.08%,CCT5;DDX3X;LARP1;NCL;LARP6;MRPS11;GNL3
prerank,four-way junction DNA binding (GO:0000400),0.32429768523736346,0.7540303636186723,0.7841269841269841,0.9915020233841912,1.0,7/17,24.06%,HMGB1;RAD51D;HMGB2;MEN1;BLM;GEN1;WRN
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.2327729899840198,-0.7494437780203576,0.856140350877193,0.9727477068703142,1.0,14/34,27.30%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.2327729899840198,-0.7494437780203576,0.856140350877193,0.9727477068703142,1.0,14/34,27.30%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.2303561986629049,-0.7490670842149039,0.8763250883392226,0.9682555229448241,1.0,10/35,17.41%,RRN3;SMARCB1;TAF4;TAF1;DR1;HDAC1;GTF2B;PIH1D1;POU2F1;UBTF
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3044726760918588,-0.7489294486791586,0.7961956521739131,0.9633994495250956,1.0,4/12,20.13%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.2708174317957759,-0.7487255878078506,0.8306878306878307,0.9587811214292848,1.0,8/17,34.16%,DPYD;BDH2;BLVRB;PTGR1;SRD5A3;PECR;PTGR2;MECR
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.36028336364206975,0.7483656868187807,0.7538200339558574,0.9973326612324509,1.0,3/11,14.44%,ITPR3;TRPC7;TRPC5
prerank,death receptor binding (GO:0005123),0.3392507831690708,0.7472923562198825,0.7719594594594594,0.9961196675621011,1.0,5/15,20.14%,DAB2IP;MADD;CASP8AP2;BID;BDNF
prerank,NADPH binding (GO:0070402),-0.29427238932575966,-0.7461020423382434,0.8190954773869347,0.9575274886365677,1.0,6/13,28.00%,DUS2;NDOR1;CRYZ;CBR3;GRHPR;DHFR
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.32033736471128293,-0.7458991567970629,0.8096446700507615,0.9529380173755481,1.0,4/10,25.39%,NAA60;NAA50;NAA10;NAA15
prerank,protein phosphatase regulator activity (GO:0019888),0.27065887700914804,0.7455875087753117,0.815006468305304,0.9961255088898128,1.0,24/53,25.05%,MGAT5;PPP1R16B;SHOC2;LMTK2;PPP2R5C;PPP2R2C;ARPP19;CALM3;PPP1R15B;PPP4R1;RCAN2;BOD1;PPP1R16A;PPP1R9B;PPP1R7;PPME1;RCAN3;EIF2AK2;PPP2R5E;IGBP1;PPP1R15A;LGALS3;PPP2R2A;PPP2R1A
prerank,proton transmembrane transporter activity (GO:0015078),-0.22226372404806377,-0.7430297523238213,0.8857142857142857,0.9521549136498806,1.0,11/39,21.65%,ATP6V1B2;CLCN5;DMAC2L;COX10;COX7A2L;UQCRQ;CLCN4;UQCRH;SLC9A1;SLC11A2;ATP6V1F
prerank,nucleoside diphosphate kinase activity (GO:0004550),-0.2867777650531181,-0.7419311810019377,0.8099762470308789,0.9489750538331149,1.0,5/14,22.45%,AK5;CMPK2;AK1;NME2;NME6
prerank,voltage-gated chloride channel activity (GO:0005247),0.3672148429780082,0.7405114978344549,0.7805695142378559,1.0,1.0,3/10,10.31%,ANO6;CLCN3;CLCN1
prerank,glutathione transferase activity (GO:0004364),0.30148873846318264,0.7394278498379012,0.8091042584434655,0.999698291652891,1.0,2/23,4.89%,GSTA2;LANCL1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3288404683114663,0.737724162392288,0.7947122861586314,0.9995401304472643,1.0,4/16,22.38%,SLC44A1;SLC22A5;SLC29A4;SLC25A42
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3368909945042533,0.73772204504839,0.785234899328859,0.9969192344274813,1.0,3/12,17.38%,CNOT6L;CNOT1;CNOT2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.305716154701832,0.73658308876508,0.7729323308270677,0.9958519213524526,1.0,7/22,10.94%,CPSF1;HNRNPA0;ZC3H12A;ELAVL1;ELAVL4;ZFP36L2;EXOSC8
prerank,hexosaminidase activity (GO:0015929),0.33819658793562346,0.7363794616449474,0.75,0.993540554458112,1.0,2/12,5.33%,CEMIP2;HYAL2
prerank,alpha-actinin binding (GO:0051393),0.30250357076541096,0.7321705046359714,0.8059259259259259,0.9968894112256249,1.0,2/24,4.46%,MAGI1;PDLIM5
prerank,sodium channel activity (GO:0005272),0.2759780442101079,0.7303861318908578,0.835195530726257,0.9967482264542453,1.0,8/37,18.28%,SCN11A;SCN1B;ASIC2;GRIK5;GRIK2;SCN9A;GRIK1;SCN1A
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.33795457571029125,0.7250809461598625,0.8110367892976589,1.0,1.0,7/12,26.25%,STAT1;TBPL1;GTF2A1;RELA;H3-3A;FOS;RUVBL2
prerank,lysophospholipase activity (GO:0004622),-0.260082540352784,-0.721199692747602,0.8711484593837535,0.9697006715344773,1.0,7/20,21.07%,PLA2G4A;PNPLA7;ASPG;ABHD12;PLA2G6;ENPP2;PLA2G4C
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.28757581809035043,0.720117912793394,0.8314447592067988,1.0,1.0,9/28,20.31%,LRRK2;SGK1;PRKCG;RPS6KA1;RPS6KB1;MAPK14;MAPKAPK5;MAP2K1;MAP3K9
prerank,phospholipase activity (GO:0004620),0.2486181727263689,0.7177695525395508,0.8614609571788413,1.0,1.0,6/67,8.69%,PITPNM3;PLCB4;SMPDL3A;PNPLA6;ABHD6;GDPD1
prerank,neuropeptide binding (GO:0042923),0.3071254511895672,0.7174678200584658,0.8006279434850864,1.0,1.0,3/18,20.71%,MC4R;GPR149;SORL1
prerank,transaminase activity (GO:0008483),-0.2969287426797099,-0.7147335840836317,0.8206388206388207,0.9720913213540546,1.0,4/11,20.59%,ABAT;OAT;GOT1;AGXT
prerank,ubiquitin protein ligase activity (GO:0061630),0.22075697002340264,0.7143450482826645,0.9483667017913593,1.0,1.0,34/228,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE4A;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,DNA polymerase binding (GO:0070182),0.30880168475302194,0.7133337101068425,0.8015873015873016,1.0,1.0,3/18,10.98%,HMGB1;PTGES3;POLG2
prerank,glucuronosyltransferase activity (GO:0015020),0.3071229444328594,0.7102210134029051,0.7925696594427245,1.0,1.0,2/19,8.93%,EXT1;B3GAT2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.23661729492926387,-0.7101169872786304,0.8922558922558923,0.9726025655185341,1.0,8/25,24.62%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.2693108778813593,-0.7042541555125355,0.8620689655172413,0.9741610220600275,1.0,2/15,5.00%,AGPAT4;LPCAT2
prerank,damaged DNA binding (GO:0003684),0.25926338525906745,0.7023446129921627,0.863102998696219,1.0,1.0,9/44,15.10%,RBBP8;APEX1;FEN1;HMGB1;RAD1;ERCC4;RAD18;HMGB2;XPC
prerank,histone deacetylase activity (GO:0004407),0.3011506595167398,0.7021547767924572,0.8322981366459627,1.0,1.0,2/19,5.29%,HDAC9;HDAC11
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.24088405682963954,0.6992242657518062,0.8830694275274056,1.0,1.0,16/74,16.50%,PIK3C2A;IPPK;IDNK;PGM2L1;TRPT1;RFK;DGKH;PIK3C3;NMRK1;PIK3CB;PAPSS1;PANK3;AGK;DGKI;GK5;DOLK
prerank,palmitoyltransferase activity (GO:0016409),0.27912901974991605,0.6959775414654791,0.8595166163141994,1.0,1.0,10/28,30.32%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;ZDHHC13;GLUL;ZDHHC15;GOLGA7;ZDHHC7;ZDHHC20
prerank,phospholipid transfer activity (GO:0120014),0.2900277302811693,0.6931941908563274,0.8460365853658537,1.0,1.0,4/21,8.63%,PLTP;GLTP;CERT1;PITPNA
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.2736097720414612,-0.6909208928146614,0.8671875,0.9836292426697459,1.0,2/14,17.78%,DHRS3;AKR1A1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.1993904302233676,-0.6898342726891042,0.9642857142857143,0.980051806325929,1.0,14/49,22.76%,IKBKE;TAB3;OPTN;PRPF8;ABRAXAS2;OTUD7B;HDAC6;WDR81;SHARPIN;ZRANB1;TNFAIP3;ZRANB3;RNF168;ZFAND2B
prerank,acylglycerol lipase activity (GO:0047372),0.32462973926119193,0.6889249132321683,0.8222591362126246,1.0,1.0,3/11,22.82%,ABHD6;ABHD2;MGLL
prerank,acetyltransferase activity (GO:0016407),0.27343810469012564,0.6854924938033369,0.840782122905028,1.0,1.0,2/31,5.21%,SATL1;LCAT
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.26473041107381895,0.6852715542548032,0.8698060941828255,1.0,1.0,5/35,16.15%,TRDMT1;TRPT1;TRMT5;ELAC2;GATB
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.279453851512919,-0.6835804821690658,0.8637469586374696,0.9810176940110857,1.0,6/12,23.24%,TENT5A;TENT4B;TUT1;TENT5D;PAPOLB;PAPOLA
prerank,RNA stem-loop binding (GO:0035613),-0.2787266598102208,-0.6821532052751045,0.8693467336683417,0.9776037819112419,1.0,5/12,19.31%,DDX3X;EPRS1;CPEB3;RC3H1;LARP6
prerank,cysteine-type peptidase activity (GO:0008234),0.23596291975345454,0.6819040558274098,0.9211195928753181,1.0,1.0,17/73,21.84%,CASP8;USP38;CASP2;TINAGL1;CASP1;USP12;USP29;USP9Y;CASP7;USP35;CTSK;CTSO;MALT1;CTSH;USP47;USP14;USP30
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.3184557438794727,0.6786748544236618,0.8544520547945206,1.0,1.0,11/11,68.18%,HCN1;KCNA10;CNGA1;CNGB1;CNGA3;CNGA4;CNGA2;AQP1;CNGB3;HCN4;HCN2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.20955308955558163,0.6776402672164471,0.9716088328075709,1.0,1.0,33/232,15.05%,TRIM14;ZNRF1;TRIM69;CBL;HERC2;TRIM11;TRIM6;RNF38;RNF125;RNF185;ARIH1;CUL3;UBE2D1;TRIM24;WWP1;UBE3A;RNF128;RNF115;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;TRIM17;NEDD4L;DTX3L;SMURF1;FBXO2;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1
prerank,sequence-specific mRNA binding (GO:1990825),0.32957141763507164,0.677347572840396,0.8461538461538461,1.0,1.0,2/10,9.64%,ETF1;DHX9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.26274524907831076,0.6743687707336633,0.891583452211127,1.0,1.0,5/33,10.43%,RNF125;RNF185;ARIH1;SIAH2;RNF144B
prerank,ATPase activator activity (GO:0001671),0.2846136117551589,0.6740002234185709,0.8710166919575114,1.0,1.0,6/20,20.23%,MYBPC3;DNAJB6;AHSA1;TOR1AIP2;DNAJC10;DNAJA1
prerank,single-stranded DNA binding (GO:0003697),0.22909775599430465,0.673776136765195,0.9467455621301775,1.0,1.0,17/93,15.87%,RBBP8;SSBP1;RTF1;PURA;POLR2G;STN1;HMGB1;DHX9;POLR2D;NUP35;POLA1;PCBP1;ERCC4;RAD51D;HMGB2;XPC;SPRTN
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.3210150577113276,0.6730475839196213,0.8471001757469244,1.0,1.0,2/11,9.69%,UBE4A;RBX1
prerank,tRNA binding (GO:0000049),-0.19608902349222862,-0.6712024039699874,0.963855421686747,0.982825959484552,1.0,11/43,17.15%,NEMF;SSB;TERT;AIMP1;TRMT9B;EIF2AK4;IGHMBP2;RPUSD4;DALRD3;ELP5;PTCD1
prerank,voltage-gated sodium channel activity (GO:0005248),-0.22830256717859737,-0.6700076547740542,0.9261363636363636,0.9792156241635378,1.0,3/22,6.67%,SCN7A;SCN2A;CACNA1G
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.261983291156366,-0.6698674646801518,0.8903394255874674,0.9746823324803695,1.0,4/15,16.66%,SH3PXD2B;PLA2G4A;PLEKHF1;JPH2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.2824070162363317,0.6686635186981708,0.8774002954209749,1.0,1.0,4/21,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,protein phosphatase activator activity (GO:0072542),-0.27365816404924553,-0.6674353667875608,0.8779761904761905,0.9721919049165777,1.0,3/13,10.37%,CALM2;IGFBP3;B3GAT3
prerank,acyl-CoA hydrolase activity (GO:0047617),0.2951033852340873,0.6671624438453031,0.8541996830427893,1.0,1.0,2/17,10.04%,PPT1;ACOT13
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.3276262890288811,0.6659458791419847,0.8350340136054422,1.0,1.0,3/10,16.68%,ANKRD13A;LAPTM5;DAXX
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.2788155337677544,0.6636691160889173,0.8595419847328244,1.0,1.0,2/21,11.89%,GRIA1;GRM5
prerank,kinase inhibitor activity (GO:0019210),-0.204035271402414,-0.6635883158763302,0.9480968858131488,0.971063470584377,1.0,8/33,16.23%,PARVA;DNAJC3;DUS2;GMFB;SH3BP5;QARS1;CDKN1A;PRKRIP1
prerank,chemokine binding (GO:0019956),0.25876888859888153,0.6635589556378599,0.8962655601659751,1.0,1.0,4/30,14.74%,CCR1;HMGB1;CX3CR1;CXCR4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.22581129894596086,0.662512001881367,0.9469135802469136,1.0,1.0,19/75,25.34%,ABCC4;GFUS;LDHC;GLYR1;LDHD;ME3;LDHAL6B;ADH5;HADHB;CBR1;HADHA;HADH;KCNAB1;KCNAB2;HSD17B4;AKR1B10;RDH11;RDH12;HMGCR
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2721529501270142,0.6601895144998983,0.8854003139717426,1.0,1.0,1/24,2.50%,ZDHHC22
prerank,N-methyltransferase activity (GO:0008170),0.27991124310225346,0.6595602665119316,0.8724727838258165,1.0,1.0,7/20,20.58%,METTL5;SETD3;TFB2M;METTL18;TRMT1L;GNMT;TRMT1
prerank,phosphatidate phosphatase activity (GO:0008195),0.3071205227606595,0.6580023548942768,0.8774834437086093,1.0,1.0,3/13,15.81%,PLPP1;PLPP4;PLPPR1
prerank,chemokine receptor binding (GO:0042379),-0.20012948011633325,-0.6557857291794376,0.9471830985915493,0.972477331213326,1.0,18/35,43.90%,CXCL16;CCL25;CXCL12;CKLF;CCL19;CCL2;CCL14;CCL28;CCRL2;CX3CL1;CCL5;CXCL5;CCL11;CXCL1;PF4;CCL7;PPBP;CCL8
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.3077735446712253,0.6509639876654097,0.847682119205298,1.0,1.0,1/11,5.80%,ARG1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.31177949093589924,0.6489948017334098,0.8508474576271187,1.0,1.0,1/11,5.95%,APEX1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.2305404274765488,0.6477586454306756,0.9334186939820742,1.0,1.0,16/57,23.04%,NDUFS4;NDUFA12;NDUFB5;COX5A;NDUFB7;CYB561A3;UQCRFS1;CYBRD1;UQCRC1;COX15;COX6A1;NDUFB4;CYB5A;NDUFA9;NDUFV1;NDUFC1
prerank,voltage-gated anion channel activity (GO:0008308),0.291258618581381,0.6455074039456571,0.8812785388127854,1.0,1.0,5/15,19.52%,ANO6;CLCN3;CLCN1;VDAC1;VDAC3
prerank,O-methyltransferase activity (GO:0008171),-0.27091117598183867,-0.6430193962437075,0.9,0.9775623691217573,1.0,5/10,28.34%,CMTR1;ASMT;BCDIN3D;COMT;CMTR2
prerank,microtubule motor activity (GO:0003777),-0.18595677164227853,-0.6404895564073287,0.9920318725099602,0.9749003315301719,1.0,28/51,36.88%,KIF3C;KIF21A;KIF13B;SMC3;KIF13A;DYNLRB1;KIF3A;KIF9;KIF7;KIF5C;KIF11;KIF5B;KIF21B;KIF1C;CENPE;KIF27;KIF6;KIF18B;KIFC1;KIF22;KIF4A;KIF14;KIFC3;KIF1B;KIF19;DNAH17;KIF20A;DYNC1I1
prerank,transcription coregulator binding (GO:0001221),0.23340544175938333,0.6396848112888894,0.9377431906614786,1.0,1.0,10/50,18.51%,LMO2;ZBTB16;NR1D1;CHD6;CTBP2;CTNNB1;ESR1;CNOT2;SMAD4;RELA
prerank,methyl-CpG binding (GO:0008327),-0.22116410805355358,-0.6388321701225397,0.9616519174041298,0.97147762404928,1.0,8/22,27.94%,MECP2;CXXC5;TET1;MBD3;ZBTB33;WDR77;ZCWPW1;ZBTB38
prerank,MAP kinase kinase activity (GO:0004708),0.28304276097695763,0.6335751676182579,0.8842105263157894,1.0,1.0,7/15,26.59%,LRRK2;MAPK14;MAPKAPK5;MAP2K1;MAP3K9;MAPKAPK3;MAP2K4
prerank,cytochrome-c oxidase activity (GO:0004129),0.28293515336974356,0.6306321325692118,0.8943217665615142,1.0,1.0,4/15,20.57%,COX5A;COX15;COX6A1;CYB5A
prerank,solute:sodium symporter activity (GO:0015370),0.2554842795221667,0.6301387500958321,0.9255474452554745,1.0,1.0,2/27,9.08%,SLC5A10;SLC4A9
prerank,single-stranded DNA helicase activity (GO:0017116),0.2657974248308649,0.627484024848688,0.893455098934551,1.0,1.0,3/19,15.38%,WRNIP1;DHX9;RFC2
prerank,ribosome binding (GO:0043022),0.22945131858116555,0.6268430047818093,0.9425901201602136,1.0,1.0,11/46,18.41%,ZC3H12A;ETF1;BAG6;EEF2;EIF6;EIF2S1;EIF2A;RACK1;EFL1;CCDC47;SRP19
prerank,ferrous iron binding (GO:0008198),-0.2180068594671068,-0.623026131125899,0.9572649572649573,0.9771339090973018,1.0,4/21,14.37%,EGLN3;FTO;TET2;FXN
prerank,Hsp70 protein binding (GO:0030544),0.24375436963989305,0.6229800733594771,0.9232876712328767,1.0,1.0,7/31,20.23%,NOD2;DNAJC2;MVD;PPID;DNAJC10;ERN1;DNAJA1
prerank,DNA polymerase activity (GO:0034061),0.261909337891275,0.6225972880547196,0.9150805270863837,1.0,1.0,4/22,10.98%,CHRAC1;POLK;POLA1;POLB
prerank,exopeptidase activity (GO:0008238),0.22457427110168346,0.6220532233385004,0.9546632124352331,1.0,1.0,14/50,23.05%,ACE;DPP6;DPP10;METAP2;CPM;LAP3;XPNPEP3;DPP8;CTSH;LNPEP;ERAP1;FOLH1;MME;NUDT16
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.265893232521105,-0.6178150665667966,0.9249394673123487,0.9756824440786065,1.0,5/10,32.29%,KAT2B;CDKN1A;CDKN2C;INCA1;CDKN2B
prerank,telomerase RNA binding (GO:0070034),0.2527352776597443,0.6113180405443864,0.9186390532544378,1.0,1.0,10/22,28.94%,DKC1;NHP2;XRN1;SMG7;EXOSC10;DHX36;WRAP53;HNRNPC;SMG5;NOP10
prerank,cardiolipin binding (GO:1901612),0.29604411464102975,0.6083795677234918,0.8836805555555556,1.0,1.0,1/10,5.77%,UQCC3
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.26321626305288837,-0.6076495641933973,0.9316455696202531,0.9768261031129495,1.0,3/10,14.33%,ECHDC3;EHHADH;ECHDC2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2786432737748864,0.6035291893112167,0.9079754601226994,1.0,1.0,2/13,8.80%,ENDOV;FEN1
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.2518285631563516,-0.6002372187736315,0.9323308270676691,0.9762411838095588,1.0,2/11,6.61%,HNRNPA2B1;RAD50
prerank,neuropeptide receptor activity (GO:0008188),0.23455408363506203,0.5997675166938655,0.9342105263157895,1.0,1.0,3/29,10.73%,GPR143;GAL;NPY5R
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.24937513647985893,0.5923599345795614,0.9425465838509317,1.0,1.0,2/21,10.51%,P2RX7;GRIK2
prerank,3'-5' DNA helicase activity (GO:0043138),0.2563967903193354,0.5909803959837151,0.925686591276252,1.0,1.0,6/16,26.35%,DHX9;ASCC3;BLM;WRN;HELQ;NAV2
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.20676508935579868,0.5898023083555758,0.9876390605686032,1.0,1.0,14/69,19.09%,CERS4;GLYAT;LPCAT4;NMT1;CERS6;CERS5;LPCAT3;MOGAT1;LIPT1;ZDHHC14;ZDHHC5;PLAAT3;SOAT1;ELP3
prerank,CCR chemokine receptor binding (GO:0048020),-0.18871492526123312,-0.5873357753816084,0.9806451612903225,0.9780684462183963,1.0,20/28,51.87%,CCL25;CCL19;CCR2;CCL2;CNIH4;CCL14;CCRL2;CX3CL1;CCL5;CCL11;CCL7;CCL8;MSMP;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CXCL13;CCL13
prerank,serine-type endopeptidase activity (GO:0004252),0.19738517592994897,0.5817670817254013,0.9794437726723095,1.0,1.0,6/80,11.61%,PRSS53;PCSK5;RHBDD1;FURIN;PROC;PIK3IP1
prerank,endoribonuclease activity (GO:0004521),0.22137928837695373,0.5816351047749442,0.9623430962343096,1.0,1.0,8/32,20.19%,INTS11;ENDOV;ZC3H12A;EXOG;NOB1;KHNYN;ERN1;CPSF3
prerank,muscle alpha-actinin binding (GO:0051371),0.26029638674890804,0.5810788552657115,0.9270664505672609,1.0,1.0,4/15,22.17%,PDLIM5;MYPN;PDLIM1;PRICKLE4
prerank,CXCR chemokine receptor binding (GO:0045236),-0.24203604196911188,-0.5794159121255474,0.946987951807229,0.9772992518675012,1.0,6/11,43.34%,YARS1;CXCL12;CXCL5;CXCL1;PF4;PPBP
prerank,pseudouridine synthase activity (GO:0009982),0.2609792653643179,0.5769892341302308,0.9359190556492412,1.0,1.0,3/13,17.96%,DKC1;TRUB1;RPUSD2
prerank,snoRNA binding (GO:0030515),0.22558360497154561,0.5729570643254361,0.960618846694796,1.0,1.0,8/30,24.98%,DHX37;DKC1;NHP2;DDX21;RRP9;IMP4;NUDT16;NUDT16L1
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2664155681104834,0.5720991644258112,0.9169435215946844,1.0,1.0,11/11,73.38%,PRMT7;PRMT5;FBXO11;PRMT2;PRMT6;CARM1;NDUFAF7;PRMT3;PRMT1;PRMT9;PRMT8
prerank,nucleotidase activity (GO:0008252),0.2570976544168303,0.5671754724409461,0.9409888357256778,1.0,1.0,5/15,21.79%,BPNT1;NT5C3B;NT5C2;NT5C;NT5C3A
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.2741957613225033,0.5653000332297868,0.9235880398671097,1.0,1.0,4/11,24.70%,RDH14;AKR1B10;RDH11;RDH12
prerank,purinergic nucleotide receptor activity (GO:0001614),0.254238000260611,0.5651488703309565,0.9414634146341463,1.0,1.0,4/15,23.47%,P2RX7;P2RY1;GPR34;P2RY12
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.2603767153215878,0.5638841287096115,0.9375,1.0,1.0,6/14,23.75%,ETFDH;ISCA2;NUBPL;RSAD2;RSAD1;IREB2
prerank,ribosomal small subunit binding (GO:0043024),0.24668438369708542,0.5634342995034451,0.9623824451410659,0.9991738822497257,1.0,3/17,15.60%,EIF1;NPM1;MTIF2
prerank,inward rectifier potassium channel activity (GO:0005242),0.2300618991588357,0.5617345803087974,0.9540059347181009,0.9977703492937942,1.0,1/24,2.72%,KCNN3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.27281861573854677,0.5591783841584025,0.946551724137931,0.9966840782801498,1.0,3/10,23.71%,CYBA;NCF2;NOX1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.250150908282472,0.5557784720031741,0.954468802698145,0.9958977676252089,1.0,3/14,17.57%,RPP38;ELAC2;POP1
prerank,endonuclease activity (GO:0004519),0.19377051791325597,0.5491989802638968,0.9897172236503856,0.9965224262462682,1.0,11/49,20.19%,APEX1;INTS11;ZC3H12A;FEN1;ERCC4;EXOG;NOB1;KHNYN;ERN1;ANG;CPSF3
prerank,methyltransferase activity (GO:0008168),0.199621332955489,0.5360546168540642,0.9895968790637191,0.9996592528273592,1.0,10/46,20.84%,COMTD1;MRM2;COQ3;GAMT;ARMT1;COQ5;FTSJ3;METTL4;NSUN4;LCMT1
prerank,peptide hormone receptor binding (GO:0051428),0.24802259887005643,0.535219158401855,0.9628378378378378,0.9978173838430593,1.0,11/11,75.21%,PSMC5;PTHLH;GPHA2;UCN3;GHRH;GPHB5;UCN2;VIP;CCK;ADCYAP1;GNRH1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.20462016414745024,0.5256902084673812,0.980528511821975,0.9990015932160649,1.0,6/34,19.75%,IQGAP1;IRGM;CALM3;RICTOR;MAP2K1;CAB39
prerank,NAD+ binding (GO:0070403),0.2293789356651285,0.49652237929264914,0.9787928221859706,1.0,1.0,3/12,19.20%,GLUD1;HADH;ZC3HAV1
prerank,ribonuclease P RNA binding (GO:0033204),0.2341289834626784,0.4928373090959903,0.9774696707105719,1.0,1.0,2/10,17.57%,RPP38;POP1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.2137261650474377,-0.4896768495958433,0.9811320754716981,0.9995541801914639,1.0,3/10,20.79%,CYLD;STAMBPL1;TNFAIP3
prerank,acetylcholine receptor activity (GO:0015464),0.20284519249919616,0.4861534889963746,0.9862804878048781,1.0,1.0,2/22,16.10%,CHRM3;HRH3
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.1933942515546272,-0.4714316266680785,0.9933184855233853,0.9979012677781124,1.0,1/11,4.28%,NUDT4
prerank,CoA hydrolase activity (GO:0016289),-0.17432950057536106,-0.46953667470281546,0.9863760217983651,0.9936988379614764,1.0,2/16,16.27%,ACOT11;ACOT6
prerank,serine-type peptidase activity (GO:0008236),0.15517295914962434,0.4673771260636052,1.0,1.0,1.0,5/96,8.44%,PRSS53;PCSK5;RHBDD1;FURIN;PROC
prerank,ribonuclease P activity (GO:0004526),0.21611132077177397,0.46109959882836526,0.9881956155143339,1.0,1.0,2/11,17.57%,RPP38;POP1
prerank,5'-nucleotidase activity (GO:0008253),0.20113436769537157,0.4325058780246269,0.9966777408637874,1.0,1.0,4/13,21.79%,NT5C3B;NT5C2;NT5C;NT5C3A
prerank,phosphatase activator activity (GO:0019211),0.1894191333393761,0.412373071086518,0.9952229299363057,1.0,1.0,5/14,25.95%,PPP2R5C;CALM3;PPP2R5E;PPP1R15A;CALM1
prerank,U6 snRNA binding (GO:0017070),0.18215079887309252,0.3976020974915277,0.9983277591973244,1.0,1.0,3/14,18.99%,PRPF4;DDX39B;LSM2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.17339913524598777,0.39226781914402525,0.9984051036682615,1.0,1.0,2/16,14.86%,CD38;SARM1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.17506898277655755,0.38568169980267064,1.0,1.0,1.0,2/14,14.82%,CYBA;NCF2
prerank,neuropeptide hormone activity (GO:0005184),0.1556225171231368,0.37392046467715123,0.9984615384615385,0.9988217231406434,1.0,21/22,73.34%,GAL;PENK;HCRT;GRP;CORT;OXT;AGRP;QRFP;GHRH;NPPA;UCN;CALCB;CRH;VIP;NMB;PNOC;NPFF;NPY;SPX;CCK;ADCYAP1
